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Abstract
Malignant catarrhal fever (MCF) is a lethal disease of ruminants and swine, characterized by vasculitis,
necrosis, and accumulation of activated, dysregulated cytotoxic lymphocytes in various tissues. It is
transmitted from so-called “reservoir” animal species to “indicator” animal species. Ovine
gammaherpesvirus 2 (OvHV-2) is one of several causative agents of MCF, circulating among all sheep
breeds worldwide, which represent the “reservoir” of this virus. Natural infection of sheep proceeds
without clinical symptoms. The disease is characterized by proliferation of cytotoxic T-cells, which
form perivascular infiltrates of lymphoid as well as non-lymphoid organs, leading to necrosis and tissue
destruction. However, little is known about the immunopathogenic pathways leading to disease.
Moreover, at the time when this work was initiated, only limited data were available for the situation in
sheep. Therefore, we first analyzed the cell populations targeted by the virus during natural infection of
lambs, since the range of targeted cells may be important for the pathogenesis, especially if it is different
in sheep and indicator animals, respectively. In most sheep we found a first peak of viral DNA in CD4+
T-helpercells, followed by a second peak in CD8+ cytotoxic T-cells. Both, CD4+ as well as CD8+ cells
are also found to harbor viral DNA in lymphocytes of cattle with MCF. From this finding we suggest
that rather a speciesspecific fine tuning of viral gene expression than the types of targeted cells may be
accountable for the disease. The second question addressed in this work was whether production of viral
particles leading to cell lysis is among the pathological factors of MCF. Diseases due to
gammaherpesvirus infections are mostly associated to latent infection, during which only a limited
number of viral proteins are expressed. These are important to tie the viral DNA to host chromosomes,
ensuring synchronous replication of viral DNA with cellular DNA, to provide viral DNA to each
daughter cell and likely render the host cell increased resistance against apoptosis. However, persistent
infection with Human herpesvirus 8 (HHV-8) as an exception is depending on a mixture of latently and
lytically infected cells. To address whether this may be the case during MCF as well, we produced
antisera against structural viral proteins and tested several tissue samples of experimentally infected
rabbits therewith. We detected viral proteins in epithelial and M-cells of the appendix of infected
animals. Interestingly, in situ hybridization revealed viral RNA in the infected epithelial cells but not in
M-cells. These data suggest that active OvHV-2 replication may play a role in the pathogenesis of the
disease. Thirdly, we tested the gene expression patterns of OvHV-2 and the relative abundances of host
cell transcripts in lymphocytes of diseased cattle to identify pathways possibly involved in the
pathogenesis of MCF. To this, host and virus gene expression patterns were analyzed by microarrray.
Only two regions of the viral genome were found to be transcriptionally active, one encoding a
latency-associated nuclear antigen, which can be found during latency of other gammaherpesviruses as
well. The other with no predicted open reading frame, which may represent micro RNA (miRNA). So
far miRNA was not discussed as a pathological factor of MCF and opens completely new attempts. As
could be expected, a large number of host genes related to inflammation, lymphocyte activation, cell
proliferation and apoptosis were found to be at different abundances compared to healthy animals. One
of these transcripts with decreased expression was IL-2. Since the phenotype of mice with IL-2
deficiency perfectly matches the clinical signs of MCF, we assume that IL-2 deficiency may play an
important role in the development of disease.
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1 Abstract 
Malignant catarrhal fever (MCF) is a lethal disease of ruminants and swine, characterized by 
vasculitis, necrosis, and accumulation of activated, dysregulated cytotoxic lymphocytes in 
various tissues. It is transmitted from so-called “reservoir” animal species to “indicator” 
animal species. Ovine gammaherpesvirus 2 (OvHV-2) is one of several causative agents of 
MCF, circulating among all sheep breeds worldwide, which represent the “reservoir” of this 
virus. Natural infection of sheep proceeds without clinical symptoms. The disease is 
characterized by proliferation of cytotoxic T-cells, which form perivascular infiltrates of 
lymphoid as well as non-lymphoid organs, leading to necrosis and tissue destruction. 
However, little is known about the immunopathogenic pathways leading to disease. 
Moreover, at the time when this work was initiated, only limited data were available for the 
situation in sheep. Therefore, we first analyzed the cell populations targeted by the virus 
during natural infection of lambs, since the range of targeted cells may be important for the 
pathogenesis, especially if it is different in sheep and indicator animals, respectively. In most 
sheep we found a first peak of viral DNA in CD4+ T-helpercells, followed by a second peak 
in CD8+ cytotoxic T-cells. Both, CD4+ as well as CD8+ cells are also found to harbor viral 
DNA in lymphocytes of cattle with MCF. From this finding we suggest that rather a species-
specific fine tuning of viral gene expression than the types of targeted cells may be 
accountable for the disease. The second question addressed in this work was whether 
production of viral particles leading to cell lysis is among the pathological factors of MCF. 
Diseases due to gammaherpesvirus infections are mostly associated to latent infection, during 
which only a limited number of viral proteins are expressed. These are important to tie the 
viral DNA to host chromosomes, ensuring synchronous replication of viral DNA with cellular 
DNA, to provide viral DNA to each daughter cell and likely render the host cell increased 
resistance against apoptosis. However, persistent infection with Human herpesvirus 8 (HHV-
8) as an exception is depending on a mixture of latently and lytically infected cells. To 
address whether this may be the case during MCF as well, we produced antisera against 
structural viral proteins and tested several tissue samples of experimentally infected rabbits 
therewith. We detected viral proteins in epithelial and M-cells of the appendix of infected 
animals. Interestingly, in situ hybridization revealed viral RNA in the infected epithelial cells 
but not in M-cells. These data suggest that active OvHV-2 replication may play a role in the 
pathogenesis of the disease. Thirdly, we tested the gene expression patterns of OvHV-2 and 
the relative abundances of host cell transcripts in lymphocytes of diseased cattle to identify 
pathways possibly involved in the pathogenesis of MCF. To this, host and virus gene 
expression patterns were analyzed by microarrray. Only two regions of the viral genome were 
found to be transcriptionally active, one encoding a latency-associated nuclear antigen, which 
can be found during latency of other gammaherpesviruses as well. The other with no 
predicted open reading frame, which may represent micro RNA (miRNA). So far miRNA was 
not discussed as a pathological factor of MCF and opens completely new attempts. As could 
be expected, a large number of host genes related to inflammation, lymphocyte activation, cell 
proliferation and apoptosis were found to be at different abundances compared to healthy 
animals. One of these transcripts with decreased expression was IL-2. Since the phenotype of 
mice with IL-2 deficiency perfectly matches the clinical signs of MCF, we assume that IL-2 
deficiency may play an important role in the development of disease. 
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2 Introduction 
Many problems in veterinary medicine due to viral infections have been solved or at least 
reduced thanks to strategies involving vaccination and/or eradication. None of this is true in 
the case of malignant catarrhal fever (MCF), which is associated to infection of particular 
animal species with specific gammaherpesviruses. 
Herpesviruses are large, enveloped viruses with an icosahedral capsid containing a double-
stranded DNA genome of 125-290 kbp. Taxonomically, the herpesviruses form the order 
herpesvirales, which can be subdivided into three families, i.e. the herpesviridae, the 
alloherpesviridae (herpesviruses of fish and frogs), and the malacoherpesviridae 
(herpesviruses of bivalves)[1]. The herpesviridae family comprises the herpesviruses of 
mammals, birds, and reptiles and is at present of highest medical and veterinary medical 
interest. Distinct biological properties have allowed to further divide this family into three 
subfamilies, i.e. the alphaherpesvirinae, betaherpesvirinae, and gammaherpesvirinae. 
Numerous members of the alphaherpesviruses and the gammaherpesviruses are of very high 
importance in veterinary medicine.  
Establishment of latency and reactivation is probably the most important biological feature of 
the herpesvirus life cycle. Latency (Latin: latens, to be hidden) is defined as a persistent state 
of the infection, during which productive viral replication does not take place. A latently 
infected cell harbors the entire viral genome mostly in an episomal, circular, and almost 
inactive state. Such a cell is, therefore, almost invisible for the immune system and the 
infection can persist for as long as latently infected cells survive within the originally infected 
organism. Periodically, the herpesviruses reactivate from latency to undergo replicative cycles 
with the aim to be transmitted to new hosts, thus, perpetuating their existence in nature. Based 
on these features, herpesviruses establish their main reservoir in latently infected organisms. 
A hallmark in the distinction between alphaherpesviruses and gammaherpesviruses is 
associated to the balance between latency and replicative cycle achieved upon infection of a 
susceptible cell. In general, alphaherpesviruses go primarily through the replicative cycle 
upon infection, which leads to efficient destruction of the cell and, consequently, the 
underlying tissue. Diseases associated to alphaherpesvirus infections can, therefore, be 
generally explained by tissue destruction due to lytic virus replication. In contrast, the 
gammaherpesviruses have a tendency to establish immediately a latent state of infection, 
which leads to a less pronounced tissue damage. The replicative cycle seems to be entered 
only rarely, only over short periods, and only under specific circumstances. While the 
alphaherpesviruses preferentially establish latency in long-living cells, for example neurons, 
the gammaherpesviruses have a preference for latency in the shorter-living lymphocytes. 
Therefore, the requirements to maintain latency are different between the members of the two 
subfamilies. In neurons, which do not divide and which are maintained for almost the entire 
lifespan, very little viral contribution may be required for maintaining latency. Consequently, 
only little viral activity can be observed throughout alphaherpesvirus latency. In contrast, it is 
more demanding to maintain a latent presence in dividing and maturing cells, such as 
lymphocytes, which have but a limited lifespan. Therefore, the latent state of the 
gammaherpesviruses relies strongly on certain viral activities, which, however, must not be 
recognizable for the immune system. It is easy to perceive that this latter strategy is prone to 
crisis because it demands a perfect balance between the actions of the virus and its host. Since 
lymphocytes distribute all over the organism, the latent gammaherpesvirus is equally 
dispersed. Once either the virus or the host breaks this equilibrium, a widely dispersed 
immune reaction may initiate, which may cause a severe problem for the entire organism. 
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This explains why diseases due to gammaherpesviruses may be linked with latent forms of 
the infection.  
MCF is a frequently lethal, immunopathological, viral disease, which can be caused by 
several distinct gammaherpesviruses, and which is transmitted from so-called “reservoir” 
animal species to so-called “indicator” animal species. The animal species, in which the 
viruses have formed their reservoir(s), are fully susceptible to the viral infection but do not 
succumb to MCF. Therefore, the virus can freely circulate among them without causing harm. 
In contrast, members of the indicator animal species are usually not infected by the MCF-
associated viruses, although they are susceptible to infection. While infection in those animals 
leads only rarely to successful replication and further transmission of the virus, some poorly 
understood pathogenetic mechanisms lead to the development of MCF in the accidentally 
infected members of the indicator species.  
The present work has been performed to shed more light into the pathogenesis of MCF and 
one of its causative viruses, the Ovine gammaherpesvirus 2 (OvHV-2).  
2.1 Gammaherpesviruses 
Taxonomically, the gammaherpesviruses are subdivided into four genera, i.e. 
lymphocryptovirus, rhadinovirus, macavirus, and percavirus [1]. As a rule of thumb, these 
viruses are well adapted to their respective hosts. Most often, infection proceeds without overt 
clinical disease. For example, Epstein-Barr virus (EBV), the prototype of the 
lymphocryptoviruses, has established its reservoir in humans. Disease due to EBV occurs 
mainly in immunosuppressed people, although genetic and racial predisposition may play a 
role. Similarly, Human herpesvirus 8 (HHV-8), the prototype of the rhadinoviruses, can 
establish lifelong asymptomatic infection in humans. However, it is not fully elucidated 
whether there is a natural HHV-8-reservoir in a species other than humans. In immuno-
suppressed hosts HHV-8 causes diseases such as Kaposi Sarcoma (KS), body cavity-based 
lymphoma, primary effusion lymphoma (PEL), and multicentric Castleman-syndrome 
(reviewed by [2]). Models for human rhadinovirus-associated diseases have been established 
with murine gammaherpesvirus 68 (MHV-68) and simian herpesvirus 2 (SaHV-2). However, 
other than its name suggests MHV-68 is not a mouse gammaherpesvirus but rather a virus of 
bank voles. Similarly, SaHV-2 has its reservoir in squirrel monkeys, not in primates, which 
are used as a disease model. However, interesting results may have emerged from these 
models, the question remains as to how accurate they reflect the human diseases. The 
designation “Maca” is abbreviated from malignant catarrhal fever and the genus macavirus 
comprises, consequently, a number of viruses from cloven-hoofed animals, which have either 
been detected in association with MCF, or which have high sequence similarity to those 
viruses. Known agents of MCF are alcelaphine herpesvirus 1 (AlHV-1; wildebeest-
associated), AlHV-2 (hartebeest-associated), caprine herpesvirus 2 (CpHV-2; goat-
associated), and ovine herpesvirus 2 (OvHV-2; sheep-associated). Characteristically, these 
viruses do not cause a natural disease in their reservoir hosts but may naturally cause MCF 
upon transmission to animals of the indicator host type. Thus, studying those viruses 
addresses a veterinary medical problem and addressing questions concerning the pathogenesis 
of MCF may be asked in a natural context. 
All gammaherpesviruses share a set of highly conserved genes, mainly involved in virus 
replication. However, each gammaherpesvirus has also a set of unique genes, which are 
believed to be important for preventing premature death of latently infected cells and to 
regulate viral latency in the face of a perfectly normal immune system. Those unique genes 
are far less conserved among the gammaherpesviruses. Indeed, each of these viruses has 
evolved a unique set of such genes and a unique strategy for co-existence with its natural host.  
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In the context of pathogenesis, diseases due to gammaherpesvirus infections are mostly 
associated to latent forms of the causative viruses. Since the gammaherpesvirus genomes are 
episomal during latency and since latency is established in relatively short-living cells, there 
is a problem for these viruses to maintain a sufficient level of infected cells over time. EBV, 
the prototype of the lymphocryptoviruses, expresses the latency-associated nuclear antigen 
(EBNA-1 or LANA) throughout latency, which tethers the viral genome to the host 
chromosome to facilitate viral DNA replication synchronous with cellular DNA and to 
provide viral DNA to each daughter cell during mitosis. Other gammaherpesviruses, for 
example the rhadinovirus HHV-8, have a slightly different strategy. They provide newly 
infected cells from small areas of ongoing viral replication, which means that tissues infected 
with HHV-8 contain a mixture of latently and lytically infected cells. The strategy followed 
by the macaviruses, both in terms of viral gene expression throughout disease and 
maintenance of sufficient numbers of infected cells, is still a matter of debate [3,4,5,6,7,8] and 
have been addressed in the present PhD thesis. 
2.2 Identification of MCF viruses 
MCF has been defined as a clinico-pathological response to a variety of related viral agents 
[9]. Although the disease has apparently been recognized for over a hundred years, the first 
viral agent in association with it was detected only in the 1960ies [9,10,11]. Already in the 
early 20th century, MCF was described to be infectious and to be distributable among cattle by 
the transmission of blood [12]. In 1930, Götze et al published a collection of case studies 
identifying sheep as possible reservoir for the infectious agents in Europe [13]. Around the 
same time, a South African cattle disease termed snotsiekte and the European malignant 
catarrhal fever were declared to be one and the same disease. 
In 1960, Plowright et al carried out large infection trials where blood, spleen and lymph node 
tissue from wildebeest was inoculated into cattle, which subsequently developed typical MCF 
[14]. These authors first isolated and identified a herpesvirus as the causative agent for the 
African variant of the disease and found that wildebeest serve as carrier for the virus and are 
the source for infection of cattle [10,11,14,15]. Later on, this virus became known as AlHV-1 
[9,16]. Soon it became clear that more viruses, related but not identical to AlHV-1, were also 
able to cause MCF. Interestingly or unfortunately, depending on the point of view, it has not 
been possible to isolate the other candidate viruses in cell culture. It took until the 1990ies to 
unambiguously demonstrate by hybridization and PCR that the most widely distributed of 
those viruses, OvHV-2, also belonged to the herpesvirus family [17,18,19]. The sequence of 
this virus was only published in 2007, which then led to its final classification and to the 
establishment of the genus macavirus [1,20,21]. The present work focused on OvHV-2 and its 
pathogenesis. Therefore, it was vital to have the sequence of OvHV-2 available.  
2.3 Genome 
Heart et al published on the entire sequence of an European OvHV-2 isolate, derived from a 
lymphoblastoid cell line, which was obtained from a cow with MCF (BJ1035) [20]. The 
genome consists of about 140 kbp and 73 putative open reading frames (ORF). It is organized 
in conserved blocks, interspersed by variable regions (Figure 1). The content, position and 
orientation of the genes in the conserved blocks are conserved among the sequenced 
gammaherpesviruses. The conserved genes of OvHV-2 show large homology to genes of 
herpesvirus saimiri (SaHV-2), the prototype of the rhadinoviruses, and have therefore been 
assigned the number of the related SaHV-2 genes. Some of the OvHV-2 genes in the variable 
regions have homologues in AlHV-1. Ov2.5, Ov3.5, and Ov8.5 are unique to OvHV-2. The 
nomenclature indicates the position of the genes to neighboring unique genes of AlHV-1. 
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‘Ov’ and ‘A’ stand for unique genes of OvHV-2 and AlHV-1, respectively. The unique genes 
are believed to be vital in the context of pathogenesis in vivo. For example Ov2.5 encodes for 
a lymphocyte growth factor, a functional viral IL-10, which could explain unrestricted 
lymphocyte growth in animals with MCF as well as attenuation of the immune response in 
animal species that do not succumb to MCF [22]. Therefore, the potential activity of this gene 
was of interest in the context of the current work.  
Simultaneously with the previous sequence, Taus et al published on the genomic sequences of 
an American OvHV-2 strain, which was derived from sheep [21]. Interestingly, the genome 
derived from sheep contained 74 ORFs instead of 73 as in the DNA retrieved from the cow. 
Due to a frame-shift, ORF40 and ORF41 appeared to represent two introns of a spliced gene 
in the first sequence but were identified as two separate ORFs in the sheep-derived OvHV-2 
sequence. ORF40 / 41 encode for a helicase-primase. Similar findings have been made with 
genomes of other gammaherpesviruses [23,24]. Furthermore, there were differences between 
the European and the American strains in the amino acid (aa) sequences of ORF17, Ov3, 
Ov10 and ORF73. ORF17 was predicted to encode for a maturational protease. Ov3 showed 
similarities to a cellular semaphorine. The function of Ov10 remains unclear. The differences 
within ORF73 between the two sequences clustered in the N-terminus and the repeated 
residues in the central region of the gene. OvHV-2 ORF73 shows similarity to the latency-
associated nuclear antigen (LANA) of HHV-8. Latency associated nuclear antigens are found 
in the genome of all gammaherpesviruses. They are essential for maintenance of the viral 
genome during latency and regulation of viral and cellular genes [25]. The N-terminus of 
LANA of HHV-8 binds to the core histones H2A/H2B to attach to chromosomes [26,27]. The 
C-terminus binds to the terminal repeat elements of the viral genome as well as to mitotic 
chromosomes, thereby tethering the viral genome to the host genome [28]. Both bindings are 
necessary for persistence and replication of the viral DNA. The central region was shown to 
reduce or even inhibit presentation of LANA epitopes to cytotoxic T-cells [29]. It is not yet 
known, whether or not the same functions apply for the OvHV-2 LANA orthologue. 
Therefore, the question about expression of ORF73 throughout MCF was of interest in the 
context of the present thesis. 
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Figure 1: Genome organization of OvHV-2. 
 
 
2.4 OvHV-2 in sheep 
As mentioned above, OvHV-2 is a sheep virus, circulating among all sheep breeds worldwide 
(reviewed by [30]). Although sheep represent the major reservoir for OvHV-2, the virus has 
also been detected in healthy goats. As a rule, lambs are born virus-free and are not infected 
with OvHV-2 prior to 2 – 3 months of age (reviewed by [30]). This is consistent with what 
has been observed in the context of AlHV-1, where wildebeest calves under the age of three 
months were shown to be the main source for infection of cattle [10,11,48,49]. Natural 
infection of sheep, independent of their age at the time of infection, proceeds without the 
slightest symptom of disease [31,32]. 
Viral DNA has been detected in sheep nasal secretions, suggesting that aerosols may play a 
role in transmission [33,34,35]. Apparently, shedding of high amounts of virus through nasal 
secretions occurs during primary infection but in a very limited time window of 
approximately 24 hours [35,36]. However, low levels of viral DNA can be found later on at 
intervals in nasal secretions of sheep. A rise in transcripts for structural viral proteins 
(ORF25, major capsid protein) and viral DNA copy numbers was detected up to 7 days post 
infection in lung cells of experimentally inoculated sheep [37]. This observation suggested 
that several cycles of replication may occur in the lung and that lung cells may be a source to 
produce infectious viral progeny. Importantly, nasal secretions from lytically infected sheep 
may be used as a source to transmit the infection experimentally [38]. Indeed, sheep, calves, 
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bisons, and rabbits have been successfully infected with OvHV-2 by intranasal nebulization 
of such nasal secretions [38,39,40,41]. MCF could be induced as a sequel to this way of 
transmission in calves, bisons, and rabbits. The incubation period (17 to 52 days) varied with 
the quantity of inoculated virus as determined by quantitative real-time PCR [38,40]. This is 
quite consistent with the natural incubation period of sheep, which varies between 6 and 26 
weeks [35,42,43]. In search for tissues in latently infected sheep, which contained high 
amounts of viral DNA, the following ranking was determined [35]: the highest load of 
OvHV-2 DNA was detected in the small intestine, followed by lymphnodes, lung, and 
vesicular gland. The lowest amounts were detected in skeletal muscles, cerebrum, adrenal 
glands, cornea, and kidney. These observations supported the hypothesis of OvHV-2 
transmission by the respiratory route. In addition, they suggested that, similar to HHV-8, 
veneric transmission also might play a role (reviewed by [44]). Indeed, high quantities of 
OvHV-2 DNA were detected in the ejaculates of OvHV-2-positive rams [35]. The same study 
also confirmed that OvHV-2 DNA was consistently detectable in the sheep white blood cells. 
However, the identity of the targeted blood cells in sheep remained undetermined. The 
present study, therefore, sheds light into this issue.  
Interestingly, OvHV-2-positive sheep nasal secretions can be used to transmit the infection by 
nebulization but intravenous or intraperitoneal inoculation of the same materials does not lead 
to disease [37]. This suggests that OvHV-2 produced in sheep turbinate cells may not be able 
to directly target all types of cells susceptible to OvHV-2. Indeed, it has been shown in other 
gammaherpesviruses that different viruses can be produced, depending on the type of the 
infected cell. For example, a complex of three viral glycoproteins is essential for entry of 
EBV into B-cells: gp85, gp25, and gp42. Only three-part complexes can induce fusion with 
B-cells, since B-cell entry requires binding of gp42 to human leukocyte antigen (HLA) class 
II. In contrary, gp42 inhibits the infection of epithelial cells. EBV virions carry both the three-
part and the two-part complexes. The ratio of the two influences the cell tropism of the virus. 
Virions made in B-cells lose some three-part complexes as a result of an intracellular 
interaction with HLA class II that targets the complexes to a degradative pathway. Thus B-
cell derived virions rather infect epithelial cells. Epithelial cells are the site of an additional 
amplification. They are not HLA class II positive, thus virions derived from epithelia contain 
more three-part complexes and are able to infect B-cells of a new host [45,46]. The change in 
cell tropism may be the reason why so far it was not possible to establish productively OvHV-
2-infected cell lines from PBMC. This issue will probably only become addressable for 
OvHV-2 once infectious clones of the virus similar to bacterial artificial chromosomes (BAC) 
for AlHV-1 can be made available [47].  
OvHV-2 infection in sheep seems to be efficiently maintained by the immune system, which 
is in sharp contrast to what happens in animal species that fall to MCF. In sheep, at 7 days 
post nebulization with OvHV-2, an increase in numerous immune-associated cytokines, 
representative for activation of macrophages, dendritic cells, natural killer (NK) cells, T-
helper cells type 1 (Th1) and Th2 cells as well as cytotoxic T-cells (Tc) can be observed, 
which coincides with a rapid decline of OvHV-2 DNA in the lung of affected animals [37]. 
Despite of the strong immune response, low levels of OvHV-2 DNA can be found regularly 
in nasal secretions of sheep.  
2.5 Malignant Catarrhal Fever 
MCF is a sporadic, mostly fatal disease of cattle and other cloven-hoofed animals, including 
deer, water buffalo, bison, and swine. A recent review describes the topic in more detail [30]. 
Briefly, the clinical symptoms are highly variable and the course can be peracute, subacute, or 
chronic. The first signs of MCF usually include dullness, inappetence, and elevated body 
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temperature. In addition, signs of mucosal inflammation begin to develop, including 
lachrymation, congestion of the conjunctiva and sclera, opacity of the cornea, salivation due 
to lesions in the oral cavity, increased nasal secretion as well as diarrhea 
[40,50,51,52,53,54,55,56]. Quite frequently, blood can be detected in the urine of affected 
animals. The case fatality is very high. With few exceptions, affected cattle die or have to be 
euthanized within approximately one week after onset of the disease. In deer (~48 hrs) and 
bison (~72 hrs), the disease takes even a more rapid fatal course [57]. Recently, there are 
increasing numbers of reports, emphasizing the recognition of chronic infections and 
subclinical courses in cattle, bison and deer [18,58,59,60,61,62,63].  
Furthermore, there are seasonal peaks in the occurrence of MCF cases [43]. The frequency of 
MCF within an affected herd varies from single cases to the loss of a very high percentage of 
animals, depending mainly on the target species. Deer and American buffalo seem to be 
highly susceptible [54,55,64,65,66], compared to swine and cattle [38,67,68,69]. Still, high 
morbidity outbreaks of MCF in cattle and swine have also been reported [56,70,71,72].  
Natural infection of rabbits has not been reported, but experimental infection leads to typical 
MCF symptoms such as fever, diarrhea, adipsia, anorexia and dullness [73]. Indeed, the rabbit 
model was used very successfully in the context of the present work.  
2.5.1 Post mortem findings 
Upon necropsy, widespread macroscopic lesions can be recognized, including reddening, 
erosion and ulceration in all sorts of mucous membranes, particularly in the respiratory tract, 
the esophagus, forestomacs, and intestines. Petechia and hemorrhages may also be noticed. 
The microscopic lesions include epithelial degeneration, vasculitis, hyperplasia and necrosis 
of lymphoid organs as well as interstitial infiltrations and accumulations of lymphoid cells in 
non-lymphoid tissues, particularly the brain [40,74,75,76]. Importantly, the post mortem 
findings in rabbits with MCF are quite similar to those of naturally affected animals [41,73].  
Prior to the development and routine use of polymerase chain reaction (PCR)-based methods, 
histology was regarded as the gold standard for the confirmation of suspected MCF [19].  
2.5.2 Immune responses during MCF and large granular lymphocytes  
Although the immunological tools for bovines are under-developed compared to those of 
mice and men and tools for detecting antibodies against OvHV-2 are also scarce, it is very 
well known that cattle raise a strong immune response throughout MCF. A competitive 
ELISA, using a cross-reacting monoclonal antibody against an AlHV-1 protein, has been used 
to demonstrate development of serological responses against OvHV-2 in various animal 
species [19,49,62,63,66,77,78]. Most adult sheep worldwide react positive in this assay. In 
contrast, healthy cattle usually react negative, while a considerable fraction of cattle with 
MCF react positive [19,62,78].  
Furthermore, MCF is characterized by T-cell hyperplasia involving proliferation and 
infiltration of lymphoid as well as non-lymphoid organs. Cytotoxic lymphocytes (CD8+) 
destroy the affected tissue, which results in extensive necrosis. T-helpercells (CD4+) are 
rather underrepresented. An interesting finding by Buxton et al. was that treatment of affected 
rabbits with Cyclosporin A reduced T-cell hyperplasia but did not prevent necrosis [5]. The 
low abundance of virus in affected tissue led to the hypothesis, that MCF as a disease may be 
caused by a misled activity of non-infected cytotoxic cells under the control of a small 
number of infected cells [5,6,7,79]. However, a recent study revealed a large number of viral 
DNA containing CD8+ cells in the vascular lesions of the brains of a cattle and a bison [8], 
giving raise to new discussions about the pathologic mechanisms leading to MCF.   
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Large granular lymphocytes (LGL) can be cultured from lymphnodes, thymus and spleen of 
diseased cattle, deer and rabbits [9,80]. CD4+, CD8+ as well as CD4 /CD8 double-negative 
T-cells have been grown in cell culture [7,81]. LGLs have an activated phenotype. Indeed, a 
constitutive activation of the Lck and Fyn tyrosine kinases was shown in LGLs derived from 
cattle with OvHV-2-associated MCF [79]. This finding reminds of similar observations from 
other gammaherpesviruses. For example, the latent membrane protein 2A (LMP2A) of EBV, 
the tyrosine kinase-interacting protein (Tip) of SaHV-2 as well as K15 of HHV-8 dysregulate 
lymphocyte signaling by interacting with Src family kinases such as Lyn, Fyn, Csk, and Syk, 
which are responsible for cell immortalization and activation in the absence of antigens 
[82,83,84,85]. Interestingly, all four above mentioned viral proteins have a transmembrane 
domain as well as Src homology domains. 
OvHV-2-associated LGLs do not respond to Concavalin A stimulation, i.e. are already fully 
activated, are cytotoxic and MHC-unrestricted [9,81,86,87,88]. After adaptation, most LGL 
grow in absence of exogenous IL-2 and do not express the cytokine themselves either [81].  
LGLs from cattle and rabbits with OvHV-2-associated MCF contain a mixture of circular and 
linear viral genomes, indicating that DNA replication goes on and that at least some lytic-
cycle genes must be expressed. Indeed, such LGL can be used to transmit MCF by 
intravenous or intraperitoneal injection to experimental animals [69,80,89,90,91]. In contrast, 
the OvHV-2 genome is in a circular conformation in primary PBMC of either healthy sheep 
or cattle with MCF, indicating a latent state [3]. However, linear genomes prevail in PBMC of 
rabbits with MCF, which suggests that OvHV-2 is in a replicative state. Interestingly, in 
PBMC of rabbits with AlHV-1 associated MCF, the latent state is dominant [92]. Thus, there 
may be differences between various animal species and different MCF agents, all of which 
may complicate the overall view of MCF pathogenesis. 
AlHV-1-associated LGL grow into characteristic large multinucleate foci that progress slowly 
[93]. Infectivity is strongly cell-associated and can only be further passaged by propagating 
intact cells. Following inoculation of these LGL into cattle or rabbits the animals succumb to 
MCF. This virus is, thus, referred to as the cell-associated virulent (CAV) form. After several 
passages, the cell cultures produce cell-free virus [93]. However, this form is not able any 
more to induce MCF in cattle or rabbits [94,95]. Therefore, it is termed cell-free attenuated 
(CFA). Attenuation is associated with genome rearrangements, i.e. translocation of DNA 
from the centre of the genome to areas next to or in between terminal repeat elements [95], 
thereby truncating and translocating genes. Genes involved in this attenuation are ORF50 and 
A6. ORF50 encodes for the replication and transcription activator (Rta), which is responsible 
for the induction of the lytic cycle of gammaherpesviruses [96].  
In the present work, efforts were undertaken to identify contributing new insights into this 
complex picture. Since high concentrations of viral DNA have been detected in the 
lymphnodes of cattle with MCF and since lymphnodes play a major role in directing the 
adaptive immune response, we chose to analyze the cellular gene expression patterns in 
lymphnodes of cattle with or without MCF. Originally, it had been the plan to first FACS-sort 
those cells and only then analyze their gene expression pattern. However, sorted cells did not 
yield good enough RNA quality for that purpose. Therefore, we restricted ourselves to the 
analysis of the gene expression patterns of unsorted lymphnode cells.  
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2.6 Principles of activation and attenuation of antiviral immunity 
As a general principle, incoming virus replicates first in tissue at the entry site. Most cells in 
these tissues, especially cells of the innate immune system, such as dendritic cells (DC), 
monocytes and macrophages and natural killer cells (NK) express sensors (Toll-like receptors, 
TLR) for general pathogen recognition (pathogen recognition patterns, PRP) in order to detect 
structures commonly associated to pathogens. Such structures, for example double stranded 
RNA, single stranded DNA, unmethylated CpG DNA, lipopolysaccharides, mannanns, etc., 
have been termed pathogen-associated molecular patterns (PAMPs)(reviewed by [97]). 
Depending on the activated TLR, different downstream signaling pathways are activated, 
leading to the activation of transcription factors, for example interferon regulatory factors and 
NF-kappaB (reviewed by [98]). Consequently, proinflammatory cytokines and chemokines 
are secreted, which further enhance the reaction of the innate immune system and activate the 
adaptive immune system. 
Lymphocytes represent the most important effector cells of the adaptive immune system. 
They are subdivided into B- and T-lymphocytes, which circulate through the body, scanning 
for their cognate antigens. Upon meeting a suitable antigen, they become activated, expand in 
a clonal fashion and differentiate to acquire their essential function. The range of function 
may be divided into different effector functions and regulatory functions. Once the infection 
is resolved, the number of lymphocytes decreases again, and only memory cells persist.  
Under normal conditions, at least three different signals are required to activate T-
lymphocytes (reviewed by [99]). First, a T-cell has to establish binding of its T-cell receptor 
(TCR) to an antigen, which has to be bound to a major histocompatibility complex molecule 
(MHC). As a general rule, all nucleated cells express type 1 MHC molecules (MHC-I), 
whereas MHC-II molecules are typical for professional antigen presenting cells, such as DCs. 
Accessory molecules between the two interacting cells provide the second signal, for example 
binding of CD80/86 to CD28 and of CD40 to CD40L, respectively. The third signal is 
received through the interaction of the cells with inflammatory cytokines. After stimulation, 
at least three different types of activity can be associated to different types and subtypes of the 
lymphocytes.  
T-helper cells. Naive CD4-positive (CD4+) T-lymphocytes (T-helper cells, Th) proliferate 
and differentiate into various effector subsets, which are characterized by the production of 
distinct cytokines, and which assign the cell’s specific effector functions. At least three 
distinct Th subsets are known, Th1, Th2, and Th17 [100,101]. Th1 cells elicit delayed-type 
hypersensitivity responses, activate macrophages and are highly effective in clearing 
intracellular pathogens. Th2 cells are particularly important for the production of 
immunoglobulin E and eosinophilic inflammation and may suppress cell-mediated immunity 
(reviewed by [102]). Th17 cells are involved in tissue inflammation and autoimmunity. These 
cells produce IL-17A, IL-17F, tumor necrosis factor (TNF) and IL-6 (reviewed by [103]). IL-
17 is a potent inflammatory cytokine [104]. During conventional infection with certain 
bacteria and fungi, IL-17 rapidly recruits neutrophils to clear the infection [105]. However, in 
autoimmunity, IL-17 may recruit effector T-cells into inflamed tissue [106].  
Cytotoxic T-cells. Activated CD8-positive T-lymphocytes (CD8+) also undergo clonal 
expansion and preferentially differentiate into cytotoxic T-cells (Tc). Tc recognize infected 
cells through specific interaction with peptide-loaded MHC-I. As a consequence of this 
interaction, Tc will release cytotoxins, such as perforin and granulysin to form pores in the 
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membranes of the targeted cells and allow transfer of granzymes, which eventually kill the 
cells through the apoptotic pathway [107].  
Antibody-producing cells. Naive B-cells have to bind antigen to their B-cell receptor and 
receive help from CD4+ cells in order to get activated. Consequently, they undergo clonal 
expansion and differentiate to produce and secrete antigen-specific antibodies.  
Termination of the immune response. Once the danger is overcome by the specific immune 
system, it is very important to gain control over all the activities raised against invading 
pathogens. In this context, the development and function of regulatory T-cells (Treg) is 
essential (reviewed in [108,109]). At least three types of Treg are known. First, naturally 
occurring Treg, which express FoxP3, are characterized by the surface markers CD4+ and 
CD25+. CD25 is part of the interleukin 2 (IL-2) receptor. IL-2 is a key cytokine during 
inflammation and has multiple, sometimes opposing functions. It is a potent inducer of T-cell 
proliferation, effector T-cell differentiation, and of the development of cytotoxic T-cells. 
However, reduced IL-2 levels have been shown to be associated with autoimmune disease in 
mice and were described in a patient with IL-2 receptor deficiency, who presented with 
clinical symptoms comparable to MCF [110]. Indeed, IL-2 is important for the development, 
survival, and function of naturally occurring Treg and inhibits the development of 
inflammatory Th17 cells. Expression of the IL-2 receptor on T-lymphocytes is under strict 
control of the antigen-stimulated T-cell receptor, thereby determining the magnitude of the 
immune response (reviewed by [102,111]). Naturally occurring Treg exert their function both 
directly to activated Tc and indirectly by influencing antigen-presenting cells. Consequently, 
attenuation of the activated state of the Tc will result.  
The second (Th3) and third (Tr1) types of Treg emerge only after induction. Th3 cells are 
positive for CD4 and TCR and secrete IL-10 as well as transforming growth factor beta 
(TGFβ), both of which contribute to attenuation of activated Tc. Tr1 cells are very similar but 
carry the CD8 marker instead of the CD4 marker. As yet, very little is known about the fates 
and functions of Treg in ruminants. However, it has been reported that in cattle gamma/delta 
T-cells, rather than CD4+/CD25+/FoxP3+ cells, are important for attenuating ongoing 
immune responses.  
Throughout the present work, we identified the major blood cell types targeted by OvHV-2 in 
sheep, the natural host of OvHV-2. Furthermore, we addressed the cellular gene expression 
patterns that might affect and deviate the normal course of the antiviral immune response in 
cattle with MCF in comparison to healthy cattle. 
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2.7 Development of vaccines to prevent MCF  
Since MCF is a viral disease, although caused by several distinct viruses, attempts have been 
undertaken to prevent the disease by immunization. Since the main agents, AlHV-1 and 
OvHV-2, are even serologically related [61,62,63,66,71,112,113,114], attempts were made to 
protect against OvHV-2-induced MCF by vaccinating with attenuated AlHV-1. However, this 
strategy was entirely unsuccessful [94,115]. In contrast, limited success has been achieved in 
the homologous AlHV-1-system. 
Briefly, inactivated cell-free virulent AlHV-1 C500, a pathogenic strain isolated from an ox 
with MCF [94], induced incomplete protection against intravenously (i.v.) administered cell-
free virus. Live cell-associated but not inactivated cell-associated virus protected rabbits 
against i.v. administered cell-associated virus [115]. In cattle, inactivated C500 given 
intramuscularly (i.m.) along with Freund’s adjuvant protected most animals from WA-MCF, 
whereas intra-nasally applied virulent C500 provided only partial protection [116]. 
Interestingly, only low levels of neutralising antibodies emerged following the challenge 
infections, indicating that cellular immunity might play a more important role than humoral 
immunity for protecting cattle against WA-MCF [94]. 
In this context, it is interesting to note that attenuated strains of SaHV-2, which do not cause 
tumors, may protect susceptible animals from tumor development due to challenge infection 
with wild type strains [117]. Similarly, cellular immunity was shown to be of importance 
during HHV-8 and MHV-68 infection [118,119,120]. During seroconversion, HHV-8 specific 
CD8+ T-cells are detectable [121]. These are mainly directed against lytic cycle proteins. The 
immune responses observed after HHV-8 infection are rather strong and reach their peak 1-2 
years after seroconversion. Cytotoxic T-lymphocyte responses to HHV-8 are considerably 
less frequent in KS patients than in asymptomatic HHV-8-seropositive subjects [122].  
Although the issue of vaccination was not addressed in the present work, the results obtained 
here may be of importance for the future development of such. In the first place, surface 
antigens of the incoming virus at the portal of entry may be targeted by means of antibody-
dependent immunity. As a second means, cytotoxic T-cells against viral antigens that are 
expressed intracellularly throughout the pathogenesis of MCF may help to avoid entering the 
detrimental pathway that is ensued in susceptible animals. Therefore, a major part of the 
present work concerned itself with viral gene expression in animals with MCF.  
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3 Hypotheses and aims of the thesis.  
MCF is a complex viral disease with immunopathological aspects that are relevant only in 
certain animal species but not in others. With the causative agent(s) belonging to the 
gammaherpesviruses, it had to be envisaged that not only species but also the targeted cell 
type(s) might influence the behavior of the virus and, consequently, the outcome of the 
infection. Knowing about this complexity, we wanted to address questions that were on one 
hand crucial in the context and, on the other hand, could be solved within a reasonable time.  
3.1 Aim 1. Which blood cells are targeted by OvHV-2 in sheep? 
We hypothesized that one reason behind the species-specific behavior of OvHV-2 could be 
based on the possibility that different cell populations were targeted in either sheep or cattle, 
respectively. Since OvHV-2-positive LGL could be cultured from cattle with MCF and since 
these belonged to the T-cell family with CD4+ or CD8+ or CD4 /CD8 double-negative 
phenotypes [7,81], it seemed that these cells were the major target for OvHV-2 in animals 
with MCF. At the time when this thesis was initiated, no data were available for the 
corresponding situation in sheep. Therefore, it was our first aim to analyze over time the types 
of sheep blood cells targeted by OvHV-2. The results of these experiments are presented in 
publication 1 of this thesis. 
3.2 Aim 2. Are structural viral antigens being produced in animals with 
MCF? 
At the beginning of this study, knowledge on OvHV-2 had primarily been based on clinical, 
histopathological, immunological, and DNA-based evidence. Virus encoded proteins had not 
yet been detected. Furthermore, there were conflicting models from other 
gammaherpesviruses on the viral state throughout disease, one (EBV) requiring a latent viral 
infection as basis for disease progression, the other (HHV8) requiring a mixture of latently 
and lytically infected cells for the same purpose. Moreover, animals with MCF are not known 
to transmit OvHV-2 efficiently to other animals but infectivity had been associated to certain 
tissues of rabbits with MCF. Therefore, we hypothesized that tissues with infectivity might 
contain cells with OvHV-2 structural antigens. To test this hypothesis, we generated antisera 
against a predicted capsid protein as well as against a putative tegument protein of OvHV-2. 
These antisera were used for detection of structural viral antigens in rabbits with MCF. The 
results of these experiments are presented in publication 2 of this thesis. 
3.3 Aim 3. Viral activity and host response throughout MCF 
To better understand the driving forces behind MCF, it was of high interest to study the viral 
gene expression activity in a disease-relevant organ of animals with MCF. Similarly, it was 
attractive to simultaneously look for the host response in the same tissue. Since lymphnodes 
play an important role in the specific defense against viruses and since they were known to 
contain high loads of viral DNA, we hypothesized that important knowledge could be drawn 
from analyzing both the viral gene expression pattern in those lymphnodes and the relative 
host gene expression profile in comparison to the same tissue obtained from healthy animals. 
The results of these experiments are presented in publication 3 of this thesis. 
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4 Publications resulting from this thesis 
4.1 Publication 1. Identification of peripheral blood mononuclear cells 
targeted by Ovine herpesvirus-2 in sheep 
See reprint. 
4.2 Publication 2. Ovine herpesvirus 2 structural proteins in epithelial cells 
and M-cells of the appendix in rabbits with malignant catarrhal fever 
See reprint. 
4.3 Publication 3. Malignant Catarrhal Fever of Cattle Is Associated with 
Low Abundance of IL-2 Transcript and a Predominantly Latent Profile 
of Ovine Herpesvirus 2 Gene Expression 
See reprint. 
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Identiﬁcation of peripheral blood mononuclear cells targeted by Ovine
herpesvirus-2 in sheep
Claudia S. Meier-Trummer, Beat Ryf, Mathias Ackermann *
Institute of Virology, University of Zurich, Winterthurerstrasse 266a, 8057 Zurich, Switzerland
1. Introduction
Malignant catarrhal fever (MCF) is a sporadic, usually
fatal infectiousdiseaseof cattle, other ruminant species, and
swine (Albini et al., 2003; Coulter et al., 2001; Hussy et al.,
2002; Muller-Doblies et al., 2001a; Muller-Doblies et al.,
2001b, 1998). There are two etiologically distinct forms of
MCF: (i) a wildebeest-associated form, caused by Alcela-
phine herpesvirus 1 (AlHV-1), and (ii) a sheep-associated
form (SA-MCF), occurring worldwide and caused by Ovine
herpesvirus 2 (OvHV-2). Based on their genomic sequences,
both AlHV-1 and OvHV-2 belong to the Macaviruses within
the subfamily Gamma herpesvirinae (Bridgen and Reid,
1991; Davison et al., 2009; Ensser et al., 1997; Hart et al.,
2007; Taus et al., 2007). AlHV-1 can be propagated in cell
culture (Castro et al., 1984; Plowright et al., 1960; Reid and
Rowe, 1973). In contrast, there is no permissive cell culture
system for OvHV-2, although OvHV-2-infected T-lympho-
cytes can be cultured from diseased animals (Coulter et al.,
2001; Reid et al., 1989). Therefore,much less is knownabout
OvHV-2 than about AlHV-1. Yet, due to the advent of
molecular biological techniques and publication of the
OvHV-2 sequences, some progress has been achieved in
studying OvHV-2 virology and pathogenesis in recent years
(Ackermann,2006;Andersonet al., 2007;Cunhaet al., 2008;
Hart et al., 2007;Hussyetal., 2002; Jayawardaneet al., 2008;
Rosbottometal., 2002;Tauset al., 2007;Thonur et al., 2006).
Interestingly, this progress also led to the recognition of
surprisinglyhighnumbersof cattle andbison,which survive
OvHV-2-infections with or without clinical signs of MCF
(O’Toole et al., 1997; Powers et al., 2005; Yeslbag, 2007).
Sheep, the main reservoir host of OvHV-2, remain
healthy upon natural infection with OvHV-2 (Ackermann,
2005, 2006; Hussy et al., 2002). Apparently, OvHV-2
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establishes latency in sheep peripheral blood mono-
nuclear cells (PBMC), since the OvHV-2 genome is usually
present in a circular conformation and the latency-
associated ORF73 is transcribed, whereas transcripts
corresponding to productive cycle genes ORF9 (DNA
polymerase) and ORF50 (R-transactivator) are barely
detected (Thonur et al., 2006). However, neither the
range of PBMC that can be infected in sheep nor the
dynamics of OvHV-2 infection in sheephas been subject to
systematic analysis. Such knowledge may be valuable for
better understanding the pathogenesis of clinical MCF in
its differences to the subclinical pathogenesis of OvHV-2
in sheep. In order to progress in this direction, we took
advantage of progeny from a speciﬁc OvHV-2-free ﬂock of
sheep (Hussy et al., 2001; Muller-Doblies et al., 2001b),
which was divided into two groups. One group of lambs
remained in isolation, whereas their siblings were
introduced into a conventional ﬂock of sheep with a
history of OvHV-2 circulation. At intervals, blood was
taken from both groups, the peripheral blood mono-
nuclear cells (PBMC) were sorted, and the sorted cells
were subjected to real-time PCR for OvHV-2-DNA in order
to identify the major PBMC subpopulations that were
targeted by OvHV-2. Using this approach, the CD2-
positive lymphocytes were identiﬁed as the major acute
and long-term target of OvHV-2 in sheep. Interestingly,
the subpopulation carrying the highest load of viral DNA
changed in the course of time after infection.
2. Material and methods
2.1. Animals
Six lambs in the age of 14–16 weeks were transferred
from our speciﬁc pathogen free (SPF) OvHV-2-negative
ﬂock to an OvHV-2-positive ﬂock. Five of the six animals
were twins. Twins were divided to the two groups. Four of
the six lambs of the positive and three of the negative ﬂock
were intact males. The original negative herd consisted of
one ram and six adult females. The original OvHV-2-
positive ﬂock consisted of ﬁve adult females and three
lambs, all of which were tested positive for OvHV-2. All
animals were kept under conventional conditions. They
were fed hay ad libitum and allowed daily access to
pasture. During the experiment none of the animals
developed clinical signs. Due to aggressive behavior all
male lambs of the negative herd had to be castrated. One
blood sample of each lambwas taken before the beginning
of the trial to conﬁrm that all lambs were OvHV-2-
negative. Thereafter blood samples were taken in weekly
intervals.
2.2. Sample preparation
10ml EDTA blood was taken from each animal at
weekly intervals. 40ml ammonium chloride buffer
(155mM NH4Cl, 10mM KHCO3, 0.1mM Na2EDTA in
bidest, pH 7.4) were added to lyse the erythrocytes. After
10min, the samples were centrifuged and the supernatant
was discarded. The pellet, containing the buffy coat cells,
was then resuspended in PBS-A (137mM NaCl, 2.7mM
KCl, 10mM Na2HPO4, 2mM KH2PO4, pH 7.4) for ﬂuores-
cence activated cell sorting (FACS) (see below).
2.3. Fluorescence activated cell sorting (FACS) and sorting
strategy
All samples were kept on ice and shielded from light
during the entire procedure. Buffy coat was washed three
times with PBS-A and incubated for 22min at 4 8C in the
dark with PBS-A containing a mixture of diluted primary
antibodies against CD2, CD4 and CD14 or CD8, respec-
tively. After washing with PBS-A, the cells were incubated
under the same conditions for 22min with PBS-A contain-
ing the secondary antibodies (Table 1). Then, the cells were
sorted in a FACSAria Flow Cytometer (Becton Dickinson)
using the following strategy. Conditions for forward scatter
(FSC) and side scatter (SSC, orthogonal light scatter) were
adopted from the literature (Salzman et al., 1975;
Thompson et al., 1985). First, the granulocytes and cell
doublets were excluded by gating. In addition, we used
previously described lymphocyte markers CD2 (Giegerich
et al., 1989; Mackay et al., 1988), CD4 (Mackay et al., 1986;
Maddox et al., 1985), CD8 (Ezaki et al., 1987;Maddox et al.,
1985) and CD14 (Jacobsen et al., 1993) (Table 2), to
separate CD2 and CD4 double positive cells, CD2-positive
and CD4-negative cells as well as CD14 positive and CD2-
negative cells from the ‘‘Rest’’, which comprised the cells
negative for all three markers (CD2/CD4/CD14)
(Fig. 1). The sort was considered complete once 500,000
cells from each subpopulation had been accumulated.
To verify the accuracy of the sorting process a small
aliquot of the sorted cells was reanalyzed using the same
gates and settings as for the sorting process.
2.4. DNA extraction
Each 500,000 sorted cells were used as startingmaterial
for DNA extraction. DNA was prepared using the DNeasy
Kit (Qiagen, Hombrechtikon, Switzerland) according to
manufacturer’s instructions. The columns containing the
puriﬁed DNA were eluted with 200ml of double distilled
water. The amount of eluted DNA representing the DNA
content of 25,000 cells was used in real-time PCR.
2.5. Real-time PCR
Real-time PCR for quantiﬁcation of OvHV-2-DNA was
done as described previously, with some modiﬁcations
Table 1
Parameters used to separate leukocyte populations.
Enrichment for Sort according
to cell size
and granularity
(FSC/SSC)a
CD2b CD4b CD14b
T-helper cells + Positive Positive Negative
Cytotoxic T-cells + Positive Negative Negative
Monocytes + Negative Negative Positive
‘‘Rest’’ + Negative Negative Negative
a See also Fig. 1.
b Labeling with antibodies to be used as positive or negative sorting
criteria.
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(Hussy et al., 2001). Brieﬂy, 100 ng template (in 10ml)
were mixed with 25ml Taqman Universal PCR Mix
(Applied Biosystems) substituted with primers and probe.
To control for unspeciﬁc inhibition, each sample was
additionally tested at a dilution of 1:10 (10 ng DNA
template). The test was considered valid when an
appropriate Ct-difference was observed between the two
dilutions. Furthermore, all samples were re-tested using a
SYBR green-based qPCR targeting the Ov9 gene, essentially
as described previously (Meier-Trummer et al., 2009).
For correlating the DNA input per sample to the
corresponding cell numbers, the 18S Genomic Control
Table 2
Antibodies and working dilution used to stain cells for FACS.
Antibody Supplier Clone Isotype Working dilution
18 Mouse a-CD4a VMRD GC50A1 IgM 1:750
18 Mouse a-CD8aa VMRD CACT80C IgG1 1:750
18 Mouse a-CD14a VMRD MM61A IgG1 1:750
18 Mouse a-CD2b VMRD 36F-18 IgG2a 1:750
28 Goat a Mouse IgG1-Cy5 Southern Biotech 1070-15 1:1000
28 Goat a Mouse IgM-PE Southern Biotech 1020-09 1:2000
28 Goat a Mouse IgG2a-FITC Southern Biotech 1080-02 1:1000
a Conﬁrmed species activity against cattle, goat, sheep.
b Conﬁrmed species activity against goat.
Fig. 1. Sorting strategy (sheep #1). Buffy coat cells were stained with antibodies against CD2 (FITC), CD4 (PE), and CD14 (APC) before FACS analysis and
sorting. Panel (A) Cells were analyzed according to size (FSC, x-axis) and granularity (SSC, y-axis). P9 was discarded (granulocytes). Panel (B) Cells outside of
P2 (doublets) were discarded. Panel (C) Cells included in P1 and P2were sorted into CD2/CD4 double positive cells, CD2-positive and CD4-negative cells, and
Rest 1. Panel (D) Similarly, P1 and P2 were sorted into CD14-positive and CD2-negative cells, CD2-positive and CD14-negative cells, and Rest 2. Rest1 and
Rest 2 were combined to constitute ‘‘Rest’’.
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Kit – FAM-TAMRAby eurogentecwas used according to the
manufacturer’s instructions (Seraign, Belgium) and in
combination with Taqman Universal PCR Mix. These
assays were run in duplicate, using two different dilutions
of target DNA (10 and 1 ng). As above, the test was
considered valid when an appropriate Ct-difference was
observed.
All PCR reactions were optimized to reach a comparable
high efﬁciency (Hussy et al., 2001; Meier-Trummer et al.,
2009).
2.6. Quantiﬁcation
Two standard curves were generated, one for quanti-
ﬁcation of viral DNA and the other for correlating those
results with the number of cells in the sample. The
following formula for the standard curves was used:
y = a x + b, where y = Ct value of the sample, x = copy
number of the sample, b = intercept and a = slope. The
standard curve for quantiﬁcation of viral DNA was based
on a 10-fold dilution series of a plasmid comprising 467 nt
of the PCR target sequence. To keep a constant overall DNA
concentration in each sample, plasmid copies ranging from
10 to 106 molecules were added to a constant excess of
DNA isolated from an OvHV-2-negative sheep.
For correlation with cell numbers, DNA was extracted
from predetermined numbers of cells (103, 104, 105 or 106
of lymphocytes as measured in a Neubauer chamber).
Then, the standard curve was generated by calculating
these numbers against the Ct values obtained for 18S rRNA
from each single DNA extraction. Mean values of duplicate
samples differed by less than a Ct value of 0.4 and lay
within a 75-percentile of close to 0.7Ct.
3. Results
3.1. Natural infection of lambs with OvHV-2
Six lambs in the age of 14–16 weeks were transferred
from a controlled OvHV-2-negative ﬂock to a known
OvHV-2-positive ﬂock. Siblings of the same lambs were
kept in the negative ﬂock. EDTA blood samples were taken
from both groups of animals at weekly intervals to be
tested for OvHV-2-DNA. The time point of the ﬁrst
appearance of OvHV-2-DNA was considered as a measure
for the incubation time of the infection in each animal. The
course of its quantity was used to describe the stage of the
infection (Table 3).
A ﬁrst screening revealed that all six exposed lambs
turned positive for OvHV-2-DNA within a period of 11–12
weeks (Table 3). Speciﬁcally, lamb #2 converted in week
11 after exposure, whereas lambs #1, #4, #5, #7, and #8
converted in week 12. In contrast, their siblings (#3, #6,
#9, #10, #11, #12) in the controlled OvHV-2-negative ﬂock
remained, as expected, negative for OvHV-2-DNA. All
lambs, irrespective of exposure to OvHV-2, remained
healthy throughout the experiment. These results sug-
gested that natural infection by OvHV-2 had occurred in all
lambs of interest, within a narrow time frame and without
any negative consequences with regard to their health
status.
3.2. Fluorescence activated sorting of individual white blood
cell populations
Gamma herpesviruses are considered to have but a
narrow host range, but only little is known yet about the
natural cell range of OvHV-2. To address this issue,
ﬂuorescence activated cell sorting (FACS) was used. After
collecting buffy coat cells, the granulocytes were excluded
by gating and four fractions were enriched in order to be
tested for presence or absence of OvHV-2-DNA, i.e. (i) CD2
and CD4 double positive cells, (ii) CD2-positive cells, which
were negative for CD4, (iii) CD14-positive cells, which
were CD2-negative, and (iv) the ‘‘Rest’’, which was
negative for all markers used in the assay.
In Fig. 1, the results from a typical sorting experiment
are shown.
Reanalysis with an anti-CD8 antibodywas performed to
test, whether or not the sorted CD2-positive and CD4-
negative cells represented actually the CD8-positive
lymphocyte population. Similarly, the CD4-positive popu-
lation was re-tested for CD8-positive cells. The results of
typical experiments are shown in (Fig. 2). Indeed,
reanalysis conﬁrmed that more than 97% of the sorted
CD2-positive and CD4-negative cells proved to be CD8-
Table 3
Stages of OvHV-2-infection in naturally infected lambs.
Lamb Conversion (stage 1)a Peak in CD4+ Peak in CD8+
Week (stage 2)b Copiesc Week (stage 3)d Copiese
#1 12 13 35,120 14 7,104
#2 11 13 1,995 18 186,079
#4 12 13 349 19 12,158
#5 12 14 53,741 16 7,725
#7 12 15 691 18 704
#8 12 13 3,162 13 4,740
Siblings n.d. n.d. 0 n.d. 0
n.d.: not detected.
a Number indicates week post transfer of sheep to OvHV-2-positive ﬂock, in which OvHV-2-DNA was ﬁrst detected by PCR.
b Number indicates week, in which quantitative PCR revealed a peak value of viral DNA in CD2/CD4 double positive cells.
c Maximum number of viral DNA copies calculated to be present in CD2/CD4 double positive cells by quantitative PCR.
d Number indicates week, in which quantitative PCR revealed a peak value of viral DNA in CD2-positive/CD4-negative cells.
e Maximum number of viral DNA copies calculated to be present in CD2-positive/CD4-negative cells by quantitative PCR.
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positive. Similarly, more than 97% of the CD2-positive and
CD8-negative cells were evaluated as CD4-positive.
Indeed, reanalysis of all of the individual cell populations
provided a mean purity of each sorted cell population
ranging between 97 and 99%. Speciﬁcally, the mean purity
of the sorted cells was 98.2% for CD4-positive T-cells, 97.6%
for CD8-positive T-cells, 97.7% for CD14-positive cells, and
99.8% for cells comprised in the fraction that was negative
for all markers used (‘‘Rest’’).
3.3. Determination of virally targeted peripheral blood
mononuclear cell populations by quantitative real-time PCR
In order to determinewhether or not, and if yes, towhich
extent a sortedwhite blood cell population was targeted by
OvHV-2, DNA was extracted from 500,000 sorted cells of
each addressed population and tested by quantitative PCR
for the amount of viral DNA. As to be expected throughout
natural courses of infection, both consistent and divergent
observations were made. At speciﬁc time points, viral DNA
was detected in all of the puriﬁed cell populations analyzed
(Fig. 3). However, OvHV-2-DNAwas only rarely detected in
puriﬁed CD14-positive cells and in the Rest-fraction. The
strongest signals were consistently detected either in CD2
and CD4 double positive cells or in CD2-positive and
CD4-negative cells, which were considered to represent the
CD8-positive CTLs. However, with time, the signal shifted
more and more to the CD8-positive fraction, where the
long-term reservoir seemed to be established. With regard
to maximal values, three patterns could be discriminated
(Table 3): (1) peak in CD4+ T-cells exceeding peak in CD8+
T-cells (animals #1 and #5); (2) peak in CD8+ T-cells
exceeding peak in CD4+ T-cells (animals #2 and #4); (3)
similar peaks in both CD4+ and CD8+ T-cells (animals #7
and #8). In ﬁve of six animals, peaking values in the CD4+ T-
cells (weeks 13–15) were detected 1–6 weeks prior to the
peak in CD8+ T-cells (weeks 13–19). Only lamb #8 showed
the two peaks in the same week.
To investigate the possibility that the signal detected in
those fractions was indeed attributable to the presence of
virus in the sorted population, the probabilities for
contamination were calculated based on the purity of
the sorted cell fractions. Assuming constant ratios of cell
populations in the starting materials, Table 4 shows that
Fig. 2. Sorting and reanalysis of T-cells. Buffy coat cells were stained with CD2/FITC, CD4/PE, and CD8/Cy5 antibodies, respectively. Panel (A) shows a typical
experiment for sorting CD2/CD4 double positive cells (R1) and CD2-positive/CD4-negative cells (R2). Panel (B) shows that CD8-positive cells (R3) were
mainly CD4-negative, whereas CD4-positive cells (R4)were predominantly negative for CD8. Panel (C) Further analysis of R1 indicated that 97.7% of the CD2
and CD4 double positive cells were CD8-negative. Panel (D) Reanalysis of R2 showed that 97.6% of the CD2-positive and CD4-negative cells were CD8-
positive.
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Fig. 3. Course of OvHV-2-DNA in sorted PBL fractions from naturally infected sheep. Buffy coat cells were sorted as described in the text and OvHV-2-DNA
was measured by quantitative real-time PCR. Each panel (A–E) describes the result obtained from one individual lamb over time. The line in each panel
describes the course of viral DNA copies determined at each time point. The bars indicate the %age of signal attributed to individual contributing cell
populations. The x-axis indicates the time (weeks) after transfer of OvHV-2-negative lambs to a positive ﬂock. The Y1-axis (%, left) applies to the bars. The
Y2-axis (right, logarithmic) applies to the curve representing number of viral genomes. Note differences in the scale of the Y2-axis.
Table 4
Calculation of the number of potentially contaminating cells in the sorted subpopulations.
CD2 + /CD4+ CD2 + /CD4- CD14+ Rest
Relative amounts of white blood cell populations in adult sheepa 15.3 3.0% 6.5 0.5% 1-6% 47.5 5.3%
Average purityb 0.982 0.976 0.978 0.998
Number of sorted cellsc 491,000 488,000 489,000 499,000
Calculated number of potentially contaminating cells per 5000000 9,000 12,000 11,000 1,000
a Values according to literature (Tschuor et al., 2008; Woldehiwet and Sharma, 1990).
b Mean of 231 sorts, as determined by reanalysis.
c Average measured.
C.S. Meier-Trummer et al. / Veterinary Microbiology 141 (2010) 199–207204
Author's personal copy
the estimated number of potentially contaminating cells in
each puriﬁed fraction ranged between 1000 and approxi-
mately 12,000 among close to 500,000 sorted cells. Based
on those numbers, the probability was close to zero that
contamination was the reason for OvHV-2-DNA detection
in the puriﬁed monocyte population and the Rest cell
population.
4. Discussion
Many Gamma herpesviruses have a seemingly narrow
host range (Ackermann, 2004, 2006). However, OvHV-2
has a surprisingly broad natural host range as it may infect
a wide range of animals, including sheep, goats, cattle,
bison, deer, swine, and, at least experimentally, rabbits and
hamsters (Ackermann, 2006; Albini et al., 2003; Audige
et al., 2001; Berezowski et al., 2005; Buxton and Reid,
1980; Imai et al., 2001; Jacobsen et al., 2007; Li et al., 2008;
Loken et al., 1998; O’Toole et al., 2007; Reid et al., 1979,
1986; Schultheiss et al., 2007). Interestingly, the fate of
infected animals is vastly different, depending on the
animal species affected. In sheep, OvHV-2 is virtually
avirulent, whereas other animals, such as cattle, deer,
swine, and bison, will develop malignant catarrhal fever
(MCF) upon infection. One of the theories behind this
discrepancy is the possibility that the virus targets
different cells in different animal species. The other
explanation may be that the nature of the infected host
cell determines the pattern of viral gene expression, which,
in turn, is an important determinant for its clinical
consequences (Ackermann, 2006; Moore and Chang,
2003). Therefore, it is important to know the natural
range of cells that are susceptible to the infection with
OvHV-2.
For several reasons, this question is not trivial to
address. First, the ways of natural transmission, the dose of
infection, and the incubation times are still debated,
although OvHV-2 has been successfully inoculated into
sheep by means of nasal nebulization, using material
derived from the respiratory tract of acutely infected sheep
(Li et al., 2005; Taus et al., 2005). In order to avoid
artiﬁciality potentially caused by experimental infection,
we chose to bring a group of OvHV-2-negative sheep into a
ﬂock of sheep with a history of OvHV-2 circulation,
whereas their siblings were kept in the OvHV-2-negative
ﬂock. Under natural conditions, conventionally bred lambs
are born virus-free but convert to OvHV-2-DNA-positive
within a period of 2–6 months after birth (Hussy et al.,
2001; Li et al., 1999; Muller-Doblies et al., 2001b). While
their siblings remained free of OvHV-2, all six sheep
transferred to the ﬂockwith OvHV-2 history turned OvHV-
2-positive within a period of 11–12weeks (Table 3), which
is consistent with the literature (Hussy et al., 2002, 2001).
Interestingly, the experimental incubation time is shorter,
although dependent on the viral titer in the inoculum (Li
et al., 2005).
Second, the sheep’s immune system is not complete at
the time of birth (Cole and Morris, 1973; Reynolds and
Morris, 1983). In the ﬁrst few days after birth, a decrease in
white blood cell (WBC) counts is observed in lambs. After
reaching a minimum WBC count of about 4 106/ml, the
numbers gradually increase to reach maximal levels of
approximately 9 106/ml at the age of 6 months. During
this time, it is actually the number of lymphocytes, both T-
and B-cells, that increases. Since natural infection of lambs
with OvHV-2 essentially falls within this period of
lymphocyte expansion, it has to be kept in mind that this
process of immune maturation may also affect the
outcome of the infection. Interestingly, we did not observe
signiﬁcant differences in the leukocyte numbers and
subpopulations between OvHV-2-infected and uninfected
lambs (data not shown).
Third, with regard to animal welfare restrictions, it was
not possible to test all lambs on a daily basis. Therefore, we
chose to test all animals at weekly intervals. Consequently,
certain variations in the results had to be anticipated.
Indeed, some of the inconsistencies experienced through-
out our analyses may be attributed to this. For example, it
may be that certain viral DNA peaks were not detected in
some individuals due to those restrictions.
Despite of these limitations, it is now safe to state that
OvHV-2 in sheep predominantly targeted the CD2-positive
lymphocyte population (Fig. 3), which is most similar to its
fate in animals susceptible to MCF (Anderson et al., 2007;
Burrells and Reid, 1991; Thonur et al., 2006). According to
our observations (Table 3), three stages of the infection
were discriminated. After conversion to OvHV-2-DNA-
positive (stage 1), in themajority of the sheep a ﬁrst peak of
viral DNA was recognized in the CD4-positive cell
subpopulation, which probably represent the T-helper
cells (stage 2). Later on, the signal for viral DNA was
primarily detected in the CD2-positive and CD4-negative
cells, which constitute probably mostly of CTLs (stage 3).
However, it is important to state that OvHV-2-DNA was
occasionally also detected in all of the other sorted
populations, including the CD14-positive monocytes and
the ‘‘Rest’’ population, which probably included B-lym-
phocytes as well as gd T-cells. Although the purity of the
sorted cell subpopulations may be slightly overestimated
because we used the same criteria for sorting and
reanalysis, the signals detected in the monocytes and
the ‘‘Rest’’ population cannot be explained solely by
contamination of the sorted cells with cells from other
virus DNA-containing cell populations. However, the
CD14-positive monocytes might also turn OvHV-2-posi-
tive upon phagocytosis of decaying infected T-lympho-
cytes. Caution is advised with regard to two unexpected
shifts in the distribution of infected cell subpopulations in
week 21 (Fig. 3): the sudden appearance of a high viral
signal in the CD14 population of animal 4 and in the ‘‘Rest’’
population of animal 5 might be due to an error in labeling
the tubes.
Despite of these concerns, it may be concluded from our
observations and interpretations that the cellular host
range of OvHV-2 in sheep is not tightly restricted to one
single T-cell population. Indeed, the cells targeted by
OvHV-2 in sheep seem to be the same as in cattle
(Anderson et al., 2007; Burrells and Reid, 1991; Thonur
et al., 2006). Therefore, we suggest that, rather than the
mere types of targeted cells, a species-speciﬁc ﬁne tuning
of viral gene expression should be most important for the
pathogenesis of MCF.
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Originally, it had been our plan to also address the state
of viral infection in the sorted cells. Unfortunately, the
quality of RNA extracted after sorting did not allow
proceeding with this purpose (data not shown). In the
absence of suitable antisera, it was also not possible to
address the state of the infection in the individual cells by
immunohistology. Therefore, it remains to be determined,
which of those cells harbor replicating or latent virus,
respectively. Interestingly, a recent model of AlHV-1-
related MCF in rabbits suggests that AlHV-1, after
replicating in unidentiﬁed cells, spreads eventually to
CD8+ T-cells to establish a predominantly latent infection
(Dewals et al., 2008). From this, the same authors insinuate
that such a non-replicative infection may lead to pro-
liferation and cytotoxic behavior of those cells. Similar
observations have been reported for OvHV-2 in the context
of MCF in cattle (Meier-Trummer et al., 2009).
Although many questions still remain to be answered,
the present work provides, by describing the dynamics of
OvHV-2 infection in sheep PBMC, some progress towards
better understanding of OvHV-2 pathogenesis in sheep.
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1. Introduction
Malignant catarrhal fever (MCF) is a sporadic, usually
fatal infectious disease of cattle, other ruminant species,
and swine (Albini et al., 2003; Coulter et al., 2001; Hussy
et al., 2002; Muller-Doblies et al., 2001a,b, 1998).
There are two etiologically distinct forms of MCF: (i)
a wildebeest-associated form, caused by Alcelaphine
herpesvirus 1 (AlHV-1), and (ii) a sheep-associated form
(SA-MCF), occurring worldwide and caused by Ovine
herpesvirus 2 (OvHV-2). Based on their genomic sequ-
ences, both AlHV-1 and OvHV-2 belong to the Rhadi-
noviruses within the subfamily Gammaherpesvirinae
(Bridgen and Reid, 1991; Ensser et al., 1997; Hart et al.,
2007; Taus et al., 2007). In contrast to AlHV-1, there is no
permissive cell culture system for OvHV-2, although
OvHV-2-infected T lymphocytes can be cultured from
diseased animals (Coulter et al., 2001; Reid et al., 1989).
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A B S T R A C T
Sheep-associated malignant catarrhal fever (MCF), caused by Ovine herpesvirus 2
(OvHV-2), is a usually fatal disease of various ruminants and swine. A system for
propagation of OvHV-2 in vitro has not yet been identified, although persistently infected
cells have been derived from diseased animals and used to establish an animal model in
rabbits. OvHV-2 structural proteins have not been detected in diseased animals and the
pathogenesis of OvHV-2 infection is poorly understood.
Recently, the genomic sequence of OvHV-2 has been determined, which allowed to
predict the amino acid sequences of putative OvHV-2 structural proteins. Based on those
predictions, we have generated antisera against two putative structural proteins (ORF43
and ORF63) of OvHV-2 in order to detect sites of active virus replication in experimentally
OvHV-2-infected rabbits with signs of MCF. Although histological lesions typical of MCF
were detected in multiple tissues, those sera detected viral capsid and tegument antigens
exclusively in the appendix but not in other tissues of rabbits with MCF. More specifically,
those viral proteins were detected in epithelial cells as well as in M-cells. However, in situ
hybridization revealed that ORF63mRNAwas present in epithelial cells of infected rabbits
but not in M-cells. Our data suggest that active OvHV-2 replication takes place in certain
tissues of animals with MCF and that M-cells may play a role in the pathogenesis of MCF.
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Sheep, the reservoir host of OvHV-2, remain healthy
upon natural infection with OvHV-2 (Ackermann, 2005,
2006; Hussy et al., 2002). Apparently, OvHV-2 establishes
latency in sheep peripheral blood mononuclear cells,
since the OvHV-2 genome is usually present in a circular
conformation, while transcripts corresponding to produc-
tive cycle genes are barely detected (Thonur et al., 2006). In
contrast, cultured T cells from diseased cattle contain a
mixture of circular and linear genome configurations
indicative of amixture of latently and productively infected
cells. Therefore, such cells can be used for the infection of
experimental animals, such as rabbits and hamsters, which
consequently develop an MCF-like disease (Anderson et al.,
2007; Coulter et al., 2001; Reid et al., 1989; Thonur et al.,
2006).
Between5 and23days post-inoculation, infected rabbits
develop MCF symptoms, which are most similar to those
seen in cattle, i.e. fever, nasal and ocular discharge,
conjunctivitis and diarrhea (Anderson et al., 2007; Buxton
and Reid, 1980; Muller-Doblies et al., 2001a). Usually, they
die within 2–3 days following the first febrile reaction.
Sacrificed animals showhyperplasia of the lymphoid organs
and lymphoid vasculitis in various organs (Anderson et al.,
2007; Liggitt and DeMartini, 1980; Muller-Doblies et al.,
2001a). OvHV-2 DNA can be detected and quantified in
white blood cells as well as in proliferating lymphocytes
within affected organs (Albini et al., 2003; Baxter et al.,
1993; Hussy et al., 2002, 2001; Reid et al., 1986, 1989;
Schock and Reid, 1996). Interestingly, transcripts for the
OvHV-2 major capsid protein but not the corresponding
proteins have recently been detected in several tissues from
cattle and bisons as well as rabbits with MCF (Cunha et al.,
2008; Gailbreath et al., 2008). The similarity of the clinical,
pathological, histological, and molecular biological findings
in rabbits and bovines with MCF suggest that a comparable
pathogenesis leads to this disease, whichmakes the rabbit a
valuable in vivo model for studying MCF. Since, under
natural circumstances, MCF is hardly transmitted from one
diseased animal to the other (cattle to cattle or rabbit to
rabbit), the question arose, whether or not productive viral
replication takes place at all throughout the course of the
disease in those animals.
According to the recently determined genomic seq-
uence of OvHV-2 (Hart et al., 2007; Taus et al., 2007),
ORF43 encodes for an essential viral capsid protein, which
has homologs in other herpesviruses, such as AlHV-1
(Ensser et al., 1997) and herpes simplex virus (HSV)
(Newcomb et al., 2001). ORF63 matches to a tegument
protein of AlHV-1, which is related to UL37 of HSV (Desai
et al., 2001; Schmitz et al., 1995;Watanabe et al., 2000). To
generate antisera for immunohistological detection of
structural OvHV-2 antigens, parts of both ORFs were
expressed in Escherichia coli as glutathione S-transferase
(GST) fusion proteins. The purified proteinswere then used
for the immunization of mice to generate specific antisera.
Here we report on the detection of ORF43 and ORF63
proteins in the appendix of rabbits with MCF.
2. Methods
2.1. Infectious OvHV-2
Infectious OvHV-2 (Rosbottom et al., 2002; Swa et al.,
2001) was derived from T cells isolated from a cow that
subsequently succumbed to SA-MCF (BJ1035, from frozen
stock) and from the first passage of the same isolate in
rabbits.
2.2. PCR
The sequences of ORF43 and ORF63 are available
from Genbank (AY366191 and AY366192). DNA sequences
encoding for the ORF43 region H284-N435 and the ORF63
region N833-L944 were amplified from cosmid C33-63
using primers containing EcoRI sites for cloning of the
products into the pGEX-6P-1 vector (Table 1).
The entire coding sequences of ORF43 and ORF63 were
amplified from the same cosmid using primers containing
BamHI (ORF43) and EcoRI sites (ORF63) for cloning into a
HSV-1-based amplicon vector (pHSVPrPUC, provided by
Dr. Howard Federoff).
For PCR, template (2 ng C33-63 or 7.5 ng pEGFP-N3)
was mixed with 2ml of each primer (10 mM), 3 ml Pfu
buffer (Stratagene, Amsterdam, The Netherlands), 1 ml Pfu
polymerase (2.5 U/ml) (Stratagene), 1ml dNTP (10 mM,
Amersham Pharmacia, Biotech, Du¨bendorf, Switzerland),
in a final volume of 30 ml.
Following denaturation at 95 8C for 1 min, 35 cycles
were completed at 95 8C for 1 min, 1 min at the tempera-
ture specified for each product in Table 1, and 74 8C for the
time specified in Table 1.
2.3. GST-fusion proteins
The regions of choicewere amplified byPCR and inserted
into the EcoRI site of vector pGEX-6P-1 (Amersham). E. coli
Table 1
Primers for amplification of OvHV-2 DNA.
Oligonucleotidea Sequence (50–30)b Annealing (8C)/extension (min) Product length
Fragment 43F GATATCGAATTCCACCTAGATGAGTGTAGTc 50/1 478 bp
Fragment 43R TAGAGAATTCCTAGTTAACCTGGTTGGATc
Fragment 63F CTCCGAATTCAATCCCCAAATTTTCCTTGCc 52/1 356 bp
Fragment 63R ACGCGAATTCTTACAGCTCCTGCGTAGGCTc
43F GTCGGATCCAGGATAAAGCTCTTAGGTATGd 60/2.5 1735 bp
43R AGCGGATCCCGGGGCCCGCTACTCAGTCGd
63F CCTCTCTGGAATTCATGATGGAGAACAAGCc 55/4.5 2886 bp
63R TGGAATTCGGCTGTGAGGCCATGGCGCTACGc
a F: forward primer, R: reverse primer.
b Restriction sites underscored: cEcoRI, dBamHI.
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BL21 (Amersham) were used for expression of protein
according to the protocols of themanufacturer. After induc-
tionwith IPTG, the bacteriawere kept for 4 h at 30 8C before
being harvested. The cell pellet was suspended in a
mixture of 20 ml STE buffer (50 mM NaCl, 50 mM Tris base
pH 8.0, 5 mM EDTA), supplemented with a protease-
inhibitor cocktail (Sigma, Buchs, Switzerland) and lysozyme
(100 mg/ml). The soluble lysate containingDTTandsarcosyl
was sonicated before Triton X-100 (1% final concentration)
and STE buffer were added to a final volume of 40 ml. This
solution was mixed with glutathione sepharose beads
(Amersham) in PBS-A (0.14 M NaCl, 2.7 mM KCl, 1.4 mM
KH2PO4, 8.1 mM Na2HPO4) and incubated at 4 8C for 4 h
before washing with PBS-A and elution in 0.5 ml 10 mM
glutathione elution buffer. Similarly, GST was expressed
from the original vector without fusion partner and the
protein was purified as described above. The resulting
protein concentrations were determined in a GeneQuant II
Spectrophotometer (Amersham) at 280 nm, based on the
predicted molecular weights and calculated molar extinc-
tion coefficients (Gill and von Hippel, 1989). The eluates
were used for immunizations.
2.4. Production of labeled sense and antisense RNA
The same PCR products as used for cloning into GST-
vectors were cloned into the EcoRI site of the transcription
vector pSPT19 (Roche, Reinach, Switzerland). Prior to the
transcription and labeling reaction using the DIG RNA
labeling kit (Roche) according to the manufacturer’s ins-
tructions, theplasmidswere linearizedwithNaeI toproduce
antisense RNA (complementary to mRNA) and PvuII to
produce sense RNA (corresponding to mRNA). Briefly, 2mg
of linearized DNA were incubated with 2ml 10! NTP
labeling mixture, 2ml 10! transcription buffer, 1ml RNase
inhibitor and 2ml RNA polymerase T7 or SP6, respectively,
and incubated for 2 h at 37 8C. After DNA digestion and
ethanol precipitation, the probe was resuspended in DEPC
treated water and chemically reduced in size to about 200
nucleotides by incubating with 50ml carbonate buffer
(80 mM NaH2CO3, 120 mM Na2CO3, 60 8C, 25 min). After a
further ethanol precipitation, the pellet was resuspended in
200ml DEPC water.
2.5. Antisera against GST, GST-ORF43 protein, and GST-
ORF63 protein
Standard methods were used to immunize C57BL/6
mice with either purified GST alone or with purified GST-
fusion proteins. Preimmune sera were collected prior
to the first vaccination and the mice received two
immunizations at 3-week intervals. Mouse sera were
collected 2 weeks after the second immunization and
stored at "20 8C.
2.6. Monoclonal antibodies and conjugates
Mouse anti-Vimentin monoclonal antibody and anti-
mouse-EnVision horseradish peroxidase conjugate as well
as alkaline phosphatase-labeled anti-mouse polymer for
double staining assays were obtained from DAKO (DAKO,
Zug, Switzerland). Fluorescent Cy3 labeled conjugate was
obtained from Stehelin AG (Basel, Switzerland).
2.7. Infection of rabbits
Six New Zealand white rabbits were infected intrave-
nously with cell-associated OvHV-2. One rabbit (MP02/
1092) received 108 infected cattle T cells (BJ1035). Five
rabbits (MP02/1445; MP04/1045; MP04/1046; MP04/
1189; MP04/1190) received 108 infected rabbit T cells
taken from BJ1035 passage 1. Rabbits with clinical MCF
were euthanized between day 9 and 16 post-inoculation,
when rectal temperatures had risen to >40 8C for 2 days.
Various tissues that are affected by OvHV-2 MCF were
collected (appendix, lung, spleen, liver, mesenteric lymph
nodes and kidney) and a portion of each tissue fixed in
either 10% formal saline or zinc fixative (zinc salts
consisting of 0.1 M Tris base, 0.05% Ca acetate, 0.5% zinc
chloride and 0.5% zinc acetate). The same tissues were
taken from uninfected control rabbits. According to
histological analysis, the tissues from rabbits with MCF,
but not those from healthy rabbits, showed typical lesions
for example areas with hyperplasia of lymphoid cells
within the appendix, mesenteric lymph node and spleen,
separated from areas with ongoing necrosis/apoptosis. For
more details, see elsewhere (Anderson et al., 2007).
2.8. Immunohistochemistry
Slideswere deparaffinized in xylol and afterwardswith a
descending alcohol series and counter-stained with hae-
malaun. Endogenous peroxidase was blocked with water
supplemented with 3% H2O2 and 0.2% NaN3. To minimize
unspecific reactions, the slides were incubated for 10 min
with DAKO Protein Block Serum Free Solution (DAKO).
After washing with PBS, the slides were incubated over
night with 100ml of primary antiserum (1:500). The slides
were washed and incubated for 30 min with peroxidase
conjugate, anti-mouse-EnVision (DAKO, EnVision System
with labeled polymer HRP anti-mouse, K4001). After
washing, the slides were developed for 10–15 min with
amino-ethyl carbazole (AEC) substrate (Stehelin).
For double staining, the same DAKO EnVision System
with HRP anti-mouse was used in combination with DAKO
EnVision Doublestain System (DAKO, K1395). First, the
slides were treated as described above (primary staining).
After development of the primary staining, the slides were
incubated with DAKO Double Staining block solution and
DAKO Protein Block Serum Free. The double staining block
provides blocking of resident immunoglobulin Fc recep-
tors, which are present due to the primary immunostain-
ing. Then, mouse-anti-Vimentin monoclonal antibody was
added for 30 min, followed by 60 min incubation with
alkaline phosphatase-labeled anti-mouse polymer. The
secondary staining was visualized using Fast red phos-
phatase chromogen solution (DAKO).
2.9. In situ hybridization
In situ hybridization was done using the DIG RNA
labeling and detection kit (Roche) according to the
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manufacturer’s instructions. Briefly, slides containing
tissue sections from OvHV-2-infected rabbits or uninfec-
ted controls were deparaffinized using xylol and descend-
ing ethanol series before being pretreatedwith DEPCwater
and PBS. After HCl treatment using 200 mMHCl for 20 min,
the sections were permeabilized with 0.02 mg/ml RNase-
free Proteinase K. Sections were prehybridized for 2 h at
50 8C with 0.25 mg/ml yeast RNA in 50 ml hybridization
mix (50% deionized formamide, 4! SSC, 1! Denhard’s
solution). Hybridizationwas performed at 55 8C over night.
Each section was overlaid with 40 ml hybridization mix
containing 10% dextran sulfate, 0.6 mg/ml yeast RNA and
0.1mg/ml of DIG-labeled antisense probe or 0.1 mg/ml of
DIG-labeled sense probe.
To remove unbound RNA probe, the sections were
washed first in RNase solution (500 mM NaCl, 10 mM Tris,
pH 8, 1 mM EDTA, pH 8) containing 0.5 mg/ml RNase
(DNase free) and 100,000 U/ml RNase T1 (Roche), then at
55 8C 2 times in 2! SSC and 2 times in 0.2 SSC, before being
incubated for 2! 15 min at room temperature in blocking
solution. For immunological detection, the sections were
incubated for 1 h with 1500 mU/ml anti-digoxigenin-AP
Fab fragments (Roche) in blocking solution. After two
washings, the reaction was visualized using nitroblue
tetrazolium solution (NBT) and 5-brom-4-chloro-3-indo-
lyl-phosphate (X-phosphate) substrate. Finally, the slides
were mounted with glycergel before analysis under the
light microscope.
3. Results
3.1. Production and preliminary characterization of antisera
against ORF43 and ORF63 proteins
In order to generate antisera against putative structural
proteins of OvHV-2, antigenic parts of the ORF43 andORF63
encoded proteins were expressed as GST-fusion proteins
and purified. Similarly, GST without fusion partner was
produced. These proteinswere then used for immunization.
The specificity of the newly generated antisera was first
tested on Western immunoblots as well as in transiently
with amplicon particles transduced cell cultures (Heister
et al., 2004; Steinmann et al., 1998), which provided the
desired products as well as appropriate controls. While the
sera did not react with cells transduced with the unrelated
construct, specific signalswere observed in cells transduced
with ORF43 amplicon and immune stained with the anti-
ORF43 serum. Similarly, ORF63 protein was detected by the
anti-ORF63 antiserum. A certain loss in sensitivity was
observed in samples that had previously been fixed in
formaldehyde and embedded in paraffin (data not shown).
However, the produced antisera could be expected to
specifically recognize their antigens, even in formalin-fixed
and paraffin-embedded tissue.
3.2. Detection of OvHV-2 structural antigens in M-cells and
epithelial cells in the appendix of infected rabbits
Previously, Rosbottom et al. (2002) reported that rabbit
T cell lines supported productive OvHV-2 replication. In
addition, infectious material had been harvested from gut-
associated lymphoid tissue such as mesenteric lymph
nodes and appendix (Schock and Reid, 1996). It was
hypothesized that structural viral proteins might be
detected in such tissues of infected rabbits. When sections
from tissues (see Section 2) of OvHV-2-infected or non-
infected rabbits were analyzed by immunohistology with
mouse antisera against the putative tegument protein 63,
specific labeling was detected exclusively in sections from
the appendix of OvHV-2-infected animals. A strong signal
was visible in the top layer of the dome epithelium of five
of six infected (Fig. 1B) animals but not in uninfected
animals (Fig. 1A). The signal was absent when preimmune
sera (Fig. 1D) or sera against GST without fusion partner
(not shown) were used. This staining pattern and the
location of positive cells suggested that cells positive for
OvHV-2 tegument protein 63 might be M-cells. Since
vimentin is considered as a marker for rabbit M-cells
(Gebert, 1995; Gebert et al., 1995), the same tissues from
infected or uninfected rabbits were subjected to a
consecutive staining with a monoclonal antibody against
vimentin. While, tegument protein 63 was not detected in
tissue from uninfected rabbits, M-cells were labeled in the
same section (Fig. 1C). In contrast, double positive staining
was detected in appendices from infected rabbits, mostly
at the periphery of the domes (Fig. 1E and F). These
observations suggested that structural protein of OvHV-2
were present in M-cells.
Similarly, epithelial cells but not goblet cells in the
appendix of rabbitswithMCFwere shown to harbor OvHV-
2 antigen by immunostaining with anti-ORF43 serum
(Fig. 2). In contrast, tissues from uninfected rabbits
revealed no immunostaining. The same infected rabbit
that was negative for viral antigen in M-cells was also
negative in epithelial cells.
These results demonstrated that in five of six MCF-
affected rabbits, OvHV-2 structural antigens were present
in epithelial cells as well as in M-cells of the appendix. This
makes the link between cosmid cloned OvHV-2 nucleotide
sequences, the encoded antigens, antisera produced to
these, and viral native antigens in vivo. However, the
nature of the infection in antigen-positive cells remained
to be determined.
3.3. Detection of ORF63 mRNA in epithelial cells of the
appendix from infected rabbits
Having detected viral proteins in cells from the
appendix of OvHV-2-infected rabbits but not in other
tissues that reacted positively for viral DNA by real-time
PCR, it was of interest to further analyze the state of the
infection not only in various tissues but also at the cell
level. Preliminary testing by RT-PCR (not shown) indicated
that ORF63 mRNA was detectable in extracts from
appendix but not lung tissue of infected rabbits. Therefore,
various tissues (mesenteric lymph nodes, lung, liver,
kidney, spleen, and appendix) of rabbits with MCF were
tested by in situ hybridization for ORF63 mRNA by using a
probe anti-sense to the target. Representative results are
shown in Fig. 3. ORF63 mRNA-expressing cells were
detected exclusively with the anti-sense probe in the
appendix of all six infected rabbits but not in other tissues.
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Specificity controls in this experiment included the use of a
sense probe, which was unable to hybridize to ORF63
mRNA, omission of the probe, and hybridization on tissues
from uninfected rabbits.
Most interestingly, ORF63 mRNA was detected solely
in epithelial cells, but not inM-cells. The fact that the viral
mRNA was detected also in appendix epithelial cells from
the one infected rabbit that had not given positive signals
by immunohistology suggested that absence of detectable
viral mRNA in M-cells was not merely attributable to
a lack of sensitivity in the technique. Rather, a biological
explanation had to be considered.
4. Discussion
The main obstacle to a better understanding of the
pathogenesis of sheep-associated malignant catarrhal
fever is a lack of tools to study virus replication and other
biological properties of ovine gammaherpesvirus type 2
(Ackermann, 2005). Production and characterization of
specific antibodies against this virus has been difficult
because OvHV-2 cannot be serially propagated as free
virus in cell cultures. In the present study, we have
overcome someof these shortcomings andprovide insight
into some novel aspects of OvHV-2 pathogenesis in
rabbits with MCF.
The salient features of our work are as follows: (i)
Antisera raised against two predicted structural proteins of
OvHV-2 were able to establish the previously missing link
between clonedDNAand viral antigens in tissues of animals
with MCF. (ii) Both viral mRNA and the corresponding
proteins were found in epithelial cells of the appendix of
diseased rabbits. (iii) Viral proteinbutnot the corresponding
mRNAwas found inM-cells of the sametissue. This supports
Fig. 1. ORF63 protein in M-cells from OvHV-2-infected rabbits. Histological sections from appendix of OvHV-2 infected (B and D–F) or uninfected (A and C)
rabbits were subjected to immunohistology. (A) Uninfected rabbit, antiserum against tegument protein 63. (B) Infected rabbit, antiserum against ORF63
protein. (C) Uninfected rabbit, double stainingwith antiserum against ORF63 protein and antibody against vimentin. (D) Infected rabbit, preimmune serum.
(E) Infected rabbit, double staining with antiserum against ORF63 protein and antibody against vimentin. (F) Same as (E) with higher magnification. Black
arrow: viral antigen stained with anti-tegument protein 63 serum; red arrow: M-cells, stained with antibody against vimentin.
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the hypothesis that M-cells may play an important role in
gammaherpesvirus pathogenesis.
Based on the genomic nucleotide sequence of OvHV-2,
two genes encoding putative structural proteins were
selected for the present study, i.e. ORF43 and ORF63.
According to its predicted amino acid sequence, the ORF43
protein is a homolog of herpes simplex virus UL6, which
forms the portal for entry of the viral DNA into preformed
capsids (Newcomb et al., 2001). Similarly, ORF63 has
been predicted to encode for a tegument protein with
homology to the UL37 protein of HSV (Watanabe et al.,
2000). Therefore, detection of these two proteins can be
considered as good indicators for ongoing viral replication
in positive cells.
To generate antisera against those proteins, fragments
thereof were expressed prokaryotically as GST-fusion
proteins, which were purified and used to immunize mice.
The newly generated antisera were carefully characterized
(data not shown) before being used for immunohistology
in various tissues of rabbits with or without MCF.
Similar to previous reports, typical histological signs
of MCF were detected in appendix, lung, spleen, liver,
and kidney of experimentally OvHV-2-infected rabbits
(Anderson et al., 2007; Gailbreath et al., 2008). However,
in our experiments, detection of OvHV-2 capsid and
tegument proteins was restricted to certain cell types
in the appendix, i.e. epithelial crypt cells and M-cells.
Initially, the two cell typeswere discriminated on staining
patterns and location of positive cells within the tissue.
However, in a double staining experiment, the M-cells
were also identified by using a monoclonal antibody
against vimentin, which is considered a reliable marker
for rabbit M-cells (Gebert, 1995; Gebert et al., 1995).
When assayed by in situ hybridization, ORF63 mRNA was
detected in epithelial cells but not M-cells from the
appendix of rabbits with MCF. Since immunohistology
does not correlate well with in situ hybridization, the
epithelial cells and M-cells were discriminated in this
instance solely based on their location.
On the one hand, the above observations are in good
agreement with the presence of infectious cells in the
appendix (Anderson et al., 2007, 2008; Buxton et al., 1984;
Reid et al., 1986). On the other hand, others have reported
on transcripts for the OvHV-2 major capsid protein in a
variety of tissues from animals with MCF (Cunha et al.,
2008;Gailbreath et al., 2008). Although the corresponding
viral proteins were not assayed for in the latter case, this
seeming contradiction provokes a debate on the accuracy
and sensitivity of different detection methods or, alter-
natively, opens the possibility that biological differences
may be responsible for the disagreement. On the one
hand, it has to be considered that RT-PCR using tissue
extracts as template is likely to be more sensitive than
either in situ hybridization or immunohistology. On the
other hand, the cell providing the corresponding signal
can be identified by in situ techniques but not when using
whole tissue extracts. Furthermore, it has to be kept in
mind that we used a Scottish OvHV-2 isolate (Rosbot-
tom et al., 2002) for inoculating the rabbits, whereas
Gailbreath et al. (2008) used an American strain. Indeed,
differences between the genomic sequences of Euro-
pean and American OvHV-2 strains, which may explain
biological differences among the two, have been
described (Hart et al., 2007; Taus et al., 2007). Finally,
in our work the rabbits had been inoculated with cell-
associated virus by the artificial, though widely accepted,
intravenous route, whereas others have successfully
made use of the intranasal inoculation of rabbits with
cell-free virus (Gailbreath et al., 2008).
Despite of these reservations, detection of the OvHV-2
structural antigens in M-cells with the simultaneous
Fig. 2.ORF43 protein in epithelial cells fromOvHV-2-infected rabbits. Gut
tissues from the appendix were treated for immunohistology with anti-
ORF43 serum. (A) Non-infected rabbit. (B) Section through epithelial cells
in the crypt. (C) Section from (B) at higher magnification. Arrows: (a) viral
antigen in epithelial cells; (b) goblet cell.
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failure to detect the corresponding mRNAs is notable. M-
cells are specialized epithelial cells, located within
mucosal surfaces lining the respiratory and intestinal
tracts and capable of antigen presentation (Bockman and
Cooper, 1973; Kabok et al., 1995; Owen et al., 1986;
Sansonetti and Phalipon, 1999; Siebers and Finlay, 1996;
Tizard, 2000). They take up antigens from the lumen in
order to present them directly to lymphocytes. Interest-
ingly, antigens that enter M-cells are likely to not be
degraded but rather passed on to other cells or to the
intercellular space. Indeed, soluble macromolecules, small
particles, and evenwhole organisms are transported byM-
cells. Therefore, some bacteria and viruses can use M-cells
as a portal to enter the body (Fotopoulos et al., 2002;
Fujimura et al., 2004; Siebers and Finlay, 1996). For
example, a lymphotropic HIV-1 strain had been shown to
cross M-cell monolayers before infecting underlying
CD4(+) target cells (Fotopoulos et al., 2002).
The literature describes at least two possibilities for
maintaining gammaherpesvirus infections in a specific
organism. In the case of EBV, the EBV nuclear antigen 1
(EBNA-1) is able to efficiently tether the viral DNA to the
host chromosome, both of which are duplicated
throughout mitosis and provided to both daughter cells
(Hu et al., 2002; Oehmig et al., 2004). Thus, EBV remains
mostly latent in an infected organism. In contrast, the
latency-associated nuclear antigen (LANA; homolog to
EBNA-1) of human herpesvirus 8 (HHV-8) is much less
effective in the same task. Therefore, maintenance of
HHV-8 requires constantly ongoing viral replication, at
least in some cells (Parravicini et al., 2000). It is possible
that OvHV-2 in rabbits with MCF has a similar need for
constant viral replication. Based on our results, we
suggest a model according to which the epithelial cells in
the appendix are productively infected, releasing infec-
tious virus to the lumen. In a second step, M-cells would
take up the virus from the lumen and transport it back
into the organism for transferring it to lymphocytes,
with which they interact closely. Such a circle would
help to maintain the infection within the organism.
Furthermore, this model could explain for the presence
of structural viral antigens and the simultaneous lack of
viral mRNA in M-cells.
An interesting observation came from one rabbit that
fell sick with MCF following infection and showed ample
amounts of ORF63 mRNA in its appendix tissue but failed
to react positively with either one of the antisera against
the predicted structural OvHV-2 proteins. Apart from
purely technical explanations for this fact, it should be kept
in mind that not all individual animals undergo the same
course of disease following natural or experimental
infection with OvHV-2 (Muller-Doblies et al., 2001b; Reid
et al., 1986, 1989; Taus et al., 2005).
In conclusion, antisera raised against two predicted
structural proteins of OvHV-2 were able to establish the
previously missing link between cloned DNA and viral
antigens in tissues of animalswithMCF. Interestingly, both
viral mRNA and the corresponding proteins were found in
epithelial cells of the appendix of diseased rabbits, whereas
viral protein but not the correspondingmRNAwas found in
M-cells of the same tissue. Our data corroborate the notion
that M-cells may play a role as a possible route of entry for
gammaherpesviruses (Faulkner et al., 2000).
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Abstract
Background: Malignant catarrhal fever (MCF) is a lethal disease of cattle, characterized by vasculitis, necrosis, and
accumulation of activated, dysregulated cytotoxic lymphocytes in various tissues. Ovine gamma herpesvirus 2 (OvHV-2) is a
causative agent of MCF, which may trigger the disease through immunopathogenic pathways. Lymphocytes are the main
target of the virus. However, the pathogenic basis of the disease is still mysterious.
Methods/Findings: We hypothesized that the gene expression patterns of OvHV-2 and the relative abundances of host cell
transcripts in lymphnodes may be used to identify pathways that help to explain the pathogenesis of MCF. Therefore, viral
and host cell gene expression patterns in lymph nodes of animals with MCF and healthy controls were analyzed by
microarray. Two regions on the viral genome were transcriptionally active, one encoding an orthologue to the latency-
associated nuclear antigen (ORF73) of other gamma herpesviruses, the other with no predicted open reading frame. A vast
number of transcripts related to inflammatory processes, lymphocyte activation, cell proliferation and apoptosis were
detected at different abundances. However, the IL-2 transcript was eminent among the transcripts, which were, compared
to healthy controls, less abundant in animals with MCF. The ratio between CD4- and CD8-positive T-lymphocytes was
decreased in the lymphnodes of animals with MCF compared to healthy controls. In contrast, the same ratio was stable,
when peripheral blood lymphocytes were analyzed.
Conclusions/Significance: The phenotype of mice with a deficient IL-2-system almost perfectly matches the clinical signs
observed in cattle with MCF, which feature a significantly decreased IL-2 transcript abundance, compared to healthy cattle.
This supports the hypothesis that immunopathogenic events are linked to the pathogenesis of MCF. IL-2-deficiency may
play an important role in the process. Therefore, this work opens new avenues for research on MCF.
Citation: Meier-Trummer CS, Rehrauer H, Franchini M, Patrignani A, Wagner U, et al. (2009) Malignant Catarrhal Fever of Cattle Is Associated with Low Abundance
of IL-2 Transcript and a Predominantly Latent Profile of Ovine Herpesvirus 2 Gene Expression. PLoS ONE 4(7): e6265. doi:10.1371/journal.pone.0006265
Editor: Ding Xiang Liu, Institute of Molecular and Cell Biology, Singapore
Received December 9, 2008; Accepted June 2, 2009; Published July 15, 2009
Copyright:  2009 Meier-Trummer et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported in part by the Swiss National Science Foundation grant #3100A0-112598 to MA, the Robert and Dorothea Wyler donation,
and the University of Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: email@vetvir.uzh.ch
¤ Current address: Ludwig Institute for Cancer Research, University of California San Diego, La Jolla, California, United States of America
Introduction
Malignant catarrhal fever (MCF) is a mysterious and lethal
immunopathological disease of cattle and other cloven hoofed
animals. Etiologically, MCF can be instigated by at least two
distinct members of the Macavirus genus within the subfamily
gammaherpesvirinae, i.e. alcelaphine herpesvirus 1 (AlHV-1) and
ovine herpesvirus 2 (OvHV-2)[1]. Both viruses undergo subclinical
infections in their natural reservoir hosts, whereas so-called
indicator hosts, i.e. cattle, deer, bison, swine, succumb to MCF
[2,3,4,5,6,7,8,9,10,11]. OvHV-2 is asymptomatically endemic
worldwide in all breeds of sheep, giving cause to the occurrence
of sheep-associated MCF (SA-MCF), wherever sheep and
indicator hosts are kept in close vicinity [12,13,14]. In contrast,
AlHV-1 is asymptomatically endemic in African ungulates, for
example wildebeest, and MCF due to AlHV-1 is restricted to
African countries or may occur on other continents upon contact
of susceptible animals with infected Zoo animals [15].
The disease is characterized by the infiltration and accumula-
tion of large numbers of CD8-lymphocytes, causing vasculitis and
necrosis in a variety of tissues [10,16,17,18]. Various clinical
patterns can be discriminated, i.e. a head-and-eye form, an
intestinal form, and a cutaneous form [10,19,20]. The clinical
findings may include combinations of ocular and nasal discharge,
opacity of the cornea that may lead to blindness, diarrhea,
haematuria, erosions of the muzzle, lymphnode swelling and
eventually erosions on the skin [10,16,17]. However, the
symptoms are often not clearly attributable to one of the clinical
patterns, e.g. diarrhea occurs in nearly all affected animals.
While AlHV-1 has been isolated in the 1960ies and can be
serially propagated in cell cultures, there is no suitable monolayer
cell culture system to serially propagate OvHV-2 [2,3]. Therefore,
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it has been difficult to study OvHV-2 and its underlying
pathogenesis in either sheep or cattle. However, much progress
has been achieved in recent years due to advances in molecular
biological techniques. Initially, it was the detection and analysis of
herpesvirus-like DNA in tissues from animals with MCF, which
allowed consecutive establishment and improvement of various
PCR detection and quantification methods for OvHV-2
[6,21,22,23]. These technical developments allowed for studies
on virological, epizootological, and pathogenetical aspects of
OvHV-2 in various animal species and also for the establishment
of a very useful rabbit model of the disease [24,25,26].
OvHV-2 exhibits typical features of a gamma herpesvirus,
which has been confirmed through the recent completion of its
genomic DNA analysis [27]. OvHV-2 has a double stranded DNA
genome, which can be divided into a unique long fragment of
approximately 130 kbp and multiple copies of approximately
4 kbp terminal repeat elements. The genome encodes for at least
73 open reading frames (ORFs), 62 of which show homology to
known gamma herpesvirus genes. Among others, a gene encoding
for a latency-associated nuclear antigen (LANA), a key feature of
gamma herpesviruses, was predicted in ORF73. The other genes
are either shared with AlHV-1 or unique to OvHV-2 (Table 1).
Among this second set of genes, there are several candidates that
could provide explanations for the disease phenotype, which
includes uncontrolled multiplication of lymphocytes in various
tissues. For example, a spliced homolog of cellular interleukin 10
(vIL-10, Ov2.5) has been described, which may serve as a growth
factor for the host’s lymphocytes and which also may act
differently, depending on the animal species infected. Further-
more, two homologs to Bcl-2 (Ov4.5 and Ov9) have been
identified. These might contribute to the protection of infected
cells against intrinsic or extrinsic apoptosis, which is induced in the
course of a normal immune reaction to prevent uncontrolled
multiplication of activated lymphocytes (reviewed by [28]).
The major sites harboring high amounts of viral DNA in the
course of MCF comprise blood lymphocytes and organs of the
immune system, including spleen and lymphnodes. However, the
presence of viral DNA in each single dysregulated cell, which
contributes to the disease picture, has been a matter of debate.
Some authors believe that only a fraction of lymphocytes is
infected, whereas others argue that the frequency of virus positive
cells in vivo is being underestimated due to the lack of sensitive
methods for detection [6,24,25,29,30].
Based on these arguments, we set out to test the following two
hypotheses:
(i) Development of MCF is associated with increased survival
and multiplication of latently infected lymphocytes, which
are protected from apoptosis through functions of a specific
set of viral proteins, including Ov2.5, Ov4.5, and Ov9
(Table 1). The expression of the corresponding viral genes in
diseased animals can be measured by a viral microarray.
Survival levels of infected cells could be increased through
direct interaction of viral proteins with cellular proteins,
which regulate apoptosis in activated lymphocytes. In this
case, the gene expression patterns of the infected cells would
not necessarily be different from those of uninfected cells. In
the same assay, a predominantly lytic type of viral gene
expression was expected to be recognizable.
(ii) Alternatively, viral proteins or micro RNAs could influence
the cellular gene expression patterns, which can be
recognized through a microarray analysis of cellular gene
expression. In this case, the pathogenesis of MCF could also
be based on a dysfunctional interplay between the cells
involved in immune functions. In such a model, only a
fraction of relevant cells needs to be infected to allow for this
type of pathogenesis. Furthermore, the pattern of viral gene
expression may be distinct from that proposed in the first
hypothesis.
While a lytic type of virus infection would be difficult to explain,
in both alternative cases, the normal pathways to restrict
multiplication of activated lymphocytes by induction of apoptosis
would be disturbed, which could result in dysregulated multipli-
cation of lymphocytes as a basis for the disease phenotype.
To test these hypotheses, we generated a microarray for the
semi-quantitative detection of viral transcripts. Labeled cRNAs
were tested on the viral microarray as well as on a cattle
microarray comprising the relevant genes for analyzing the general
features of the host’s status of immune response. Important
findings were corroborated by alternative methods. We found that,
indeed, MCF was associated predominantly with a latent type of
viral gene expression and, furthermore, we may have detected an
important clue to understand and, possibly, treat MCF in the
future.
Results
Lymphnodes are one of the main sites for diagnosis of MCF and
lymphocytes are the main carriers of OvHV-2 DNA in cattle with
MCF. In order to get insight into the pathogenesis of this disease,
an effort was undertaken to analyze the cellular and viral
transcription profiles in such lymphnodes and to compare the
cellular transcription profiles of animals with MCF to those of
uninfected animals. For this purpose RNA was extracted from
OvHV-2-positive lymphnodes of cattle with MCF as well as from
OvHV-2-negative, healthy control animals. Consecutively, Cya-
nin- and biotin-labeled cRNA was produced for use in microarray
analysis and standardized as described in Materials and Methods.
Presence and quantity of selected viral RNAs was additionally
assayed by qRT-PCR.
Analysis of viral transcripts
Microarray. In a first set of experiments, the Cy3- and Cy5-
labeled cRNA was used for hybridization with an array, which
represented the entire OvHV-2 genome. Specifically, 8730 60mer
oligonucleotides were used as viral targets. These oligonucleotides
Table 1. Unique OvHV-2 genes.
Unique gene Possible function
Ov2 Regulation of transcription; leucine zipper protein
Ov2.5 Viral IL-10 (vIL-10)
Ov3 Intracellular signaling; semaphorin family
Ov3.5 No prediction, unknown
Ov4.5 Cell death regulator; Bcl-2 family
Ov5 Intracellular signaling; G-protein coupled receptor
Ov6 Viral transactivator; similarity to Zta of EBV
Ov7 Glycoprotein
Ov8 Glycoprotein
Ov9 Cell death regulator; Bcl-2 family
Ov10 Transcriptional regulation; nuclear localization signal
doi:10.1371/journal.pone.0006265.t001
MCF and Low IL-2 RNA Abundance
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represented both strands of the viral genome twice (tiling probes).
To generate a second type of screening for transcriptional activity,
two additional oligonucleotides per each predicted viral open
reading frame (ORF) were used as targets, which had been
selected for optimal hybridization under the conditions used (ORF
probes). The array was hybridized and analyzed as described in
Materials and Methods. The resulting data were deposited in the
GEO database (GSE13853). Figure 1 compares the hybridization
signals obtained from cells of infected and control animals. The
points represent the expression signal of the probes targeting the
viral genome. The majority of the probes (gray and black points)
did not show any differential signal. Only two regions on the virus
genome showed transcriptional activity. The first one covered
ORF73, which is located on the reverse strand spanning the region
119046 bp to 120533 bp and represents a LANA orthologue. In
this region 31 consecutive tiling probes showed differential signals
in the infected animals (see Figure 2). The same was also observed
by the two probes that were optimized to target the ORF73 (cyan
dots in Figure 1). Thus, transcription from ORF73 was detected
using two alternative methods.
The second region for viral transcriptional activity spanned
nucleotides 115184 to 115364 bp on the forward strand of the
viral genome and was represented by four consecutive tiling
probes. This region corresponds to an intergenic region, located
between ORF69 and ORF Ov8. This observation was unexpected
and invites for further analysis.
qRT-PCR. The present microarray was designed only to
provide relative information towards viral transcriptional activity
throughout MCF. In order to validate the presence of the
transcripts predicted by the viral microarray and to explore the
sensitivity of the present assays, a number of quantitative reverse
transcription real-time PCR (qRT-PCR) assays were established
(see Materials and Methods) and used for detection and
quantitation of selected viral RNAs in lymphnodes of cattle with
MCF. The results are summarized in Table 2. Briefly, the
sensitivity of the assay to detect ORF25 template was comparable
to that for detecting the intergenic target, whereas the tests to
detect ORF73 and Ov9 were more sensitive. Under these
conditions, the ORF25 transcript, encoding the major capsid
protein of OvHV-2, remained undetectable in our materials,
Figure 1. Hybridization signals. Comparison of the hybridization signals of infected (MCF-diseased) and control animals on the viral microarray.
The tiling and ORF specific probes are plotted in gray and black. We have highlighted the probes matching the LANA homologue (blue/cyan) and 4
consecutive tiling probes targeting the region 115250 bp on the forward strand (red).
doi:10.1371/journal.pone.0006265.g001
Figure 2. OvHV-2 gene expression. Expression pattern in the region 119 kB to 121 kB of the virus. The plot shows the expression changes
measured by the probes tiled across the genome and the predicted location of the LANA gene. Probes above (below) the dividing line match the
forward (reverse) strand. Significant consistent induction is measured by the probes matching the reverse strand at the locus of ORF73 (LANA
orthologue).
doi:10.1371/journal.pone.0006265.g002
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whereas the intergenic transcript was present at high numbers.
Similarly, between 100 and 1.000 copies of the ORF73 transcript
were detected using the same amount of template that did not
reveal any transcriptional activity over Ov9. Calculating
conservatively, the microarray used throughout our experiments
had a detection limit of less than 100 copies per assay.
From all of the above experiments we conclude that no
transcripts corresponding to structural viral proteins were
detected. These results supported the notion that MCF was
associated with a predominantly latent OvHV-2 infection.
However, they also clearly, contradict hypothesis 1, which
predicted that several viral genes would be expressed, which are
unique to OvHV-2 or shared with AlHV-1 (see Table 1). Indeed,
no significant transcriptional activity in any of those genes was
detected under the present experimental conditions.
Analysis of host transcripts in animals with and without
MCF
The biotin-labeled cRNAs were also used for hybridization with
an Affymetrix Bovine Genome array, which consisted of 24.072
probe sets, each comprising 11 oligonucleotides, covering over
23.000 bovine transcripts. 15.425 probe sets were considered as
present by our filtering. The subsequent statistical analysis
revealed significant expression differences (p,0.05) between
infected and uninfected animals for 6.300 probe sets. The resulting
data were submitted to the GEO database (GSE13852).
Apparently 4.538 transcripts were significantly more abundant
in diseased animals as compared to healthy animals. Furthermore,
1.770 transcripts were significantly less abundant in animals with
MCF. 1.238 transcripts were found to be more than twice as
abundant in diseased than in healthy animals. The highest value of
higher abundance (256-fold) was found with a transcript for
granzyme-2, a T-cell serine protease, which is transcriptionally
activated during cytotoxic T-lymphocyte maturation. The detailed
data were deposited in the GEO database (GSE13852).
Inflammation and T-cell activation. As expected from the
etiology and the clinical disease picture, primarily transcripts
related to inflammatory processes, lymphocyte activation, catalytic
processes, immune response, cell proliferation and apoptosis were
detected at different abundance. Unexpectedly, the IL-2 transcript
was eminent among the transcripts of low abundance. Since IL-2
is strictly regulated on the transcriptional level [31] and because it
occupies a pivotal role in the regulation of the immune response
and due to the fact that IL-2 deficient mice show a similar
phenotype to cattle with MCF, i.e. accumulation of lymphocytes in
the intestine and ulcerative colitis [32,33], we suggest that its low
abundance in the context of inflammation and T-cell activation
may represent a key feature of MCF.
The transcripts for the IL-17 receptor, MHC-I heavy chain, IL-
6 receptor alpha chain, insulin receptor, and IL-16 receptor were
among the most strongly reduced transcripts. On the other hand,
the expression of IL-10 and its receptor were slightly increased. An
interesting phenomenon was observed with various clusters of the
T-cell receptor (TCR). While the TCR beta cluster (Bt63956) was
in low abundance, other beta clusters as well as the gamma cluster
were significantly increased (Table 3). A number of transcripts
belonging to the effector molecules of cytotoxic T-cells, e.g.
granzymes and perforin, as well as transcripts indicating the
lymphocytes to be activated, e.g. CD2, CD3, CD8 were detected
at higher abundance. The Interferon gamma transcript itself was
6.4 times more abundant in animals with MCF, and in accordance
with this we observed that among 21 interferon-related transcripts,
20 were found to be more abundant and only 1 was less abundant.
The outstanding higher abundance of transcripts belonging to
catalytic processes may be explained by the predominance of
cytotoxic T-cells in MCF lesions.
Cell cycle/Apoptosis associated transcripts. Several cell
cycle and apoptosis related transcripts were present at different
abundance in healthy and MCF-diseased cattle, respectively
(Table 4). Interestingly, the transforming growth factor beta
(TGF beta) as well as its receptor (TGFbR), which together control
proliferation and differentiation of many cell types, was less
abundant in animals with MCF. This is noteworthy since TGF
beta is, similar to IL-2, important in the context of regulatory T-
cells. The complexity of the present situation may be explained by
the simultaneous influence of the virus and host control
mechanisms on affected lymphocytes.
Overall, these results were consistent with hypothesis 2, which
claimed that the host gene expression of animals with MCF was
affected in a manner that could be detected by microarray analysis
and that could explain the disease phenotype without all
dysregulated cells being infected. However, it remains to be
clarified, whether these observations are caused by differential
gene expression regulation of the cells or by their mere numbers
and abundances.
CD4/CD8 ratios
The relative abundance of transcripts in a given compartment
may be explained either by downregulation/upregulation of
transcriptional activity or by loss/proliferation of the major
producer cells of a particular transcript. To address this issue as
far as possible, CD4/CD8 ratios were determined in the
peripheral blood as well as in the lymphnodes of cattle with
MCF and healthy controls. As shown in Fig. 3., the CD4/CD8
ratios in the bloodstream did not significantly differ between
healthy animals and such with MCF (p= 0.97). In contrast, the
same ratios were significantly lower in cattle with MCF compared
to healthy controls (p = 0036), when assayed in lymphnodes. Due
to the nature of the lymphnode, absolute counts of the relevant
cells could not be generated. Therefore, the observed low
abundance of IL-2 transcripts in lymphnodes of cattle with
MCF might be interpreted either as due to (1) over-proportional
proliferation of CD8+ cells and downregulation of IL-2 transcrip-
tion in CD4 cells or (2) strong decline of the CD4+ cells, which are
the main IL-2 producers, or (3) a combination thereof. However, it
was obvious that the number and fate of lymphocytes in the
lymphnodes may differ from the situation in the periphery.
In any event, our results strongly suggest that the low
abundance of IL-2 transcripts in lymphnodes of cattle with
Table 2. qRT-PCR for selected viral RNAs in lymphnodes.
Target DNAa Melting peakb RNA (MCF)c RNA (healthy)d
ORF25 100–1000 n.a. Not detected Not detected
ORF73 .10 81uC 100–1.000 Not detected
Ov9 .10 81uC Not detected Not detected
Intergenic .100 83uC 500–10.000 Not detected
adetection limit (number of template copies) using DNA template.
bdetermined following qPCR using SYBR-green technology; not applicable (n.a.)
to conventional PCR, which was detected by EtBR staining after agarose gel
electrophoresis of the PCR product.
c25 ng RNA template (from lymphnodes of animals with MCF) before reverse
transcription. Numbers in the column refer to copy number detected.
d25 ng RNA template (from lymphnodes of healthy animals) before reverse
transcription.
doi:10.1371/journal.pone.0006265.t002
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MCF may lead to IL-2 deficiency and be an important factor in
the pathogenesis of the disease.
Discussion
Malignant catarrhal fever (MCF) in cattle is a frequently lethal
disease, which proceeds with fever, depression, conjunctivitis and
keratitis, as well as with hyperemic to ulcerative lesions in the
mucosa of the respiratory, genital and digestive tract, which lead to
ocular and nasal discharge and diarrhea [11]. Viral DNA can be
detected in buffy coat cells of cattle with MCF as well as in most
organs. In contrast, demonstration of viral antigen in cattle with
MCF has, thus far, been largely unsuccessful [2,3].
At least two agents, AlHV-1 and OvHV-2, are known to cause
MCF in cattle and it would be of interest to know, whether or not
their disease is actually based on the same pathogenetical
principles. In this work, we concentrated exclusively on OvHV-
2. Similar to other gamma herpesviruses, OvHV-2 has two sets of
genes, i.e. (1) a set of common viral genes that are conserved
among the herpesviruses and (2) a set of unique genes that often
have homologues in their host cells. Twelve (Table 1) of its 73
predicted ORFs encode for unique genes, nine (Ov2, Ov3, Ov4.5,
Ov5, Ov6, Ov7, Ov8, Ov9, Ov10) have orthologues in AlHV-1
and three are exclusive for OvHV-2 (Ov2.5, Ov3.5, Ov8.5).
It is well known from other gamma herpesviruses that the viral
gene expression pattern may correlate to the present state of the
infection or the associated disease. For example, the latency II
program of EBV drives the differentiation of activated B-cells into
memory cells [34,35] or vGCR of HHV-8 is known to induce
transformation and angiogenesis, both features, which are
required for the development of Kaposi’s sarcoma [36,37,38,39].
Although the pattern of viral gene expression in infected cells of
animals with MCF has previously not been analyzed in detail, a
recent report described the detection of the ORF25 transcript,
which encodes for the OvHV-2 major capsid gene, in animals with
MCF [40]. This observation spoke for lytic replication of OvHV-2
in diseased animals, at least upon infection with an American
OvHV-2 strain. In contrast, we were unable to detect the ORF25
transcript throughout our work, which, though, was done in the
context of European strains of OvHV-2. Interestingly, the ORF25
transcript was also not detected, when analyzed by others in the
rabbit model for AlHV-1-associated MCF [41]. The latter authors
explicitly did not detect any ORF25 (capsid protein) or ORF9
(DNA polymermase) transcripts in spleens or lymphnodes of
rabbits with AlHV-1-induced MCF. They concluded, therefore,
that AlHV-1-induced MCF is associated with a predominantly
latent infection. This view is also shared by others working with
European OvHV-2 [42]. Indeed, mainly intact circular OvHV-2
genomes have been found in T-lymphocytes derived from cattle
with MCF, which speaks for a dominating latent infection.
Furthermore, detection of structural viral antigens in the lesions of
cattle with MCF was, hitherto, unsuccessful. Moreover, OvHV-2
is rarely, if at all, naturally transmitted from one cattle to another
and it has been difficult to recover infectivity at all from cattle with
MCF [43,44,45]. Conversely, a mixture of OvHV-2 transcripts
has been detected in cultured peripheral T-lymphocytes from
cattle with MCF [29]. Those authors concluded that, at least in the
periphery, latently infected cells may co-exist with cells harboring
productively replicating OvHV-2. This view is supported by a
recent publication on OvHV-2-induced MCF in the rabbit model,
where structural OvHV-2 proteins were detected exclusively in
epithelial cells and M-cells of the appendix, while other tissues
Table 3. Transcripts associated with inflammation and T-cell activation affected in lymphnodes of MCF affected cattle.
Transcript Fold abundance p-value Function
Granzyme A 8.6 0.000372 Cytotoxic T-cell effector
Granzyme B precursor 256.2 0.0175 Cytotoxic T-cell effector
Granzyme H precursor 27.2 0.000431 Cytotoxic T-cell effector
Perforin 4.8 0.00517 Cytotoxic T-cell effector
CD2 2.4 0.00569 Adhesion molecule involved in T-cell activation
CD3e 1.7 0.00517 Essential role in TCR signal transduction and cell-surface expression of
the TCR
CD3d 1.7 0.00837
CD3c 1.5 0.00838
CD8a 3.9 0.00598 Coreceptor for MHC class I restricted T-cell s
CD28 2.2 0.00161 Costimulation of T-cell proliferation and cytokine production upon
binding CD80 or CD86
TCR, gamma cluster 4.8 0.0457 Recognition of antigen presentation
TCR, beta cluster (Bt63956) 0.4 0.0364 Recognition of antigen presentation
TCR, beta cluster (Bt1978) 1.4 0.0126 Recognition of antigen presentation
TCR, beta cluster (Bt1978) 1.4 0.00852 Recognition of antigen presentation
Interferon gamma 6.4 0.00958 Affects activation, growth, and differentiation of T-cells, B-cells and
macrophages as well as Nk cells. Upregulates MHC expression on APCs.
Antiviral and anti-proliferative activities
Interleukin 2 0.14 0.00268 Involved in propagation and establishment of self tolerance of T-cells
Interleukin 7 0.6 0.0277 Growth factor for T-cell progenitors
Interleukin 10 2.9 0.0132 Anti-inflammatory cytokine
IL-10 receptor 1.3 0.007 Anti-inflammatory response
doi:10.1371/journal.pone.0006265.t003
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contained viral DNA at detectable levels but not the correspond-
ing mRNAs or proteins [26].
However, in lymphnodes of cattle with MCF, as demonstrated
throughout our experiments, neither genes encoding for structural
proteins nor any one of the unique genes of OvHV-2 were
detected above threshold levels. Indeed, the only active gene
seemed to be ORF73. Detection of this RNA was confirmed in our
work by three different approaches. Interestingly, ORF73 (LANA)
transcripts were also detected in rabbits with AlHV-1-induced
MCF [41]. Thus, our data with OvHV-2 in cattle match very well
with the observations described for AlHV-1 in rabbits. Together,
these data imply that MCF, independent of its individual agent or
host, is associated with a predominantly latent viral gene
expression pattern, at least in certain tissues.
In addition, we detected by microarray a transcriptional
activity in a region without any predicted ORF. The existence
of this transcript was confirmed by qRT-PCR over the same
region (Table 2). Although the sensitivity of the qRT-PCR for
this transcript was below that for ORF73, the number of
molecules covering the intergenic region was higher than the
number of ORF73 transcripts. Since the detection limits of the
assays for ORF25 and intergenic RNA were comparable, the
detection of the latter RNA also corroborates the absence of the
former.
While a latency pattern, rather than a replicative pattern, of
viral gene expression could be expected in the context of MCF, the
lack of expression from the atypical genes argued against our first
hypothesis, which claimed that some of those genes and their
products might directly drive survival of the dysregulated cells.
One might predict that those genes and their products have a
function in protecting their original host from developing MCF.
Absence of their expression in cattle could even be one of the
major reasons for the development of MCF. Unfortunately,
OvHV-2 gene expression could not yet be determined in ovine
cells, primarily due to the scarcity of infected cells in sheep (own
unpublished observations).
Table 4. Cell cycle and apoptosis related transcripts affected in MCF in cattle.
Transcript Protein family Fold induction p-value
Cyclin A2 Cyclins 4.2 0.000587
Cyclin B1 7.3 0.000159
Cyclin B2 5.3 0.00247
Cyclin E2 3.7 0.0015
Fas ligand Membrane bound cytokine 5.1 0.0031
Fas Tumor necrosis factor 1.4 0.0045
Cyclin dependent kinase 2 2.2 0.00114
Cyclin dependent kinase 5 1.7 0.00458
Cyclin dependent kinase 7 1.5 0.0158
Cyclin dependine kinase 11 1.4 0.0375
BH3 domain interacting death agonist (BID) B-cell lymphoma type 2 (Bcl2) 2.2 0.000862
Bcl2-associated X protein (BAX) 2.9 0.00503
Bcl2-like 7 (BAK) 2.3 0.00275
Bcl2 1.6 0.00159
Voltage-dependent anion channel (VDAC) (3 probe sets) 2.2 Probe set 1 = 0.00077
2.0 Probe set 2 = 0.00142
1.6 Probe set 3 = 0.00186
Baculoviral IAP repeat containing 5 (survivin) Inhibitors of apoptosis (IAP) 6.3 0.00326
Siva 2.1 0.000791
T-cell specific tyrosine-protein kinase (LCK) Tyrosine-protein kinase 1.9 Probe set 1 = 0.000703
2.0 Probe set 2 = 4.2361025
1.8 Probe set 3 = 3.2861025
Apoptosis-associated speck-like protein containing a CARD
(caspase recruitment domain)
2.4 0.00248
Hsp10 Heat shock proteins (Hsp) 2 0.00158
Hsp70 0.34 0.00833
Hsp90 1.8 8.261025
Retinoblastoma protein (Rb) (2 probe sets) 2.2 9.9661025
1.5 0.004
E2F Transcription factor 2.2 5.7610
p53 Transcription factor 1.3 0.00134
TGF beta TGF beta family 0.29 0.006
TGF beta receptor 0.35 0.01
doi:10.1371/journal.pone.0006265.t004
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Host gene expression
The host gene expression profile was markedly disturbed by the
effects of the disease. One may argue, whether or not the
lymphnodes are the ideal tissue to look for viral and host gene
expression throughout MCF. They were selected for the present
study because they are known to harbor plenty of OvHV-2 infected
cells, which play an important role in the host’s immune defense
[10,22]. Moreover, the vasculitis and necrosis in affected tissue have
been attributed to the function of riotous cytotoxic lymphocytes. It
was not surprising to find a complex pattern of differences in
transcript abundances upon comparison of transcriptomes in
lymphnodes from healthy cattle and cattle with MCF.
High abundance of Cyclin and Cdk transcripts
The state of cell proliferation can be monitored through analysis
of gene expression and was reflected on the present microarray. As
the cells progress through the reproductive cycle, cyclins are
synthesized and degraded. Cyclins bind to and, thus, activate
cyclin-dependent kinases (Cdks). Activated Cdks induce expression
of more cyclins as well as degradation of the Cyclin-Cdk inhibitor
of the consequent step in the cell cycle. In contrast to cyclins, Cdk
levels remain, under normal conditions, constant throughout the
cell cycle. However, cyclin-dependent kinases are frequently
upregulated in malignancies due to overexpression of their cyclin
partners [46]. Thus, as a first marker of malignancy, a significant
higher abundance of several cyclins as well as Cdk was detected in
the lymphnodes of cattle with MCF (Table 4). This finding could
be expected since histology of lymphnodes in MCF diseased cattle
is dominated by a marked increase in lymphocytes [47], although
foci of necrosis are concurrently detected [16,17].
Activation of T-cells and unbalanced expression of
regulators of apoptosis
T lymphocyte activation can be expected upon a viral infection
of an organism or during defense against uncontrolled cell growth.
Indeed, several markers of T lymphocyte activation were more
abundant in cattle with MCF as compared to healthy animals
(Table 3). To avoid accumulation of excessive amounts of
activated T-cells, both the extrinsic and the intrinsic apoptosis
pathways will usually be induced, simultaneously with T-cell
activation. Both pathways lead to the activation of a family of
cystein proteases called caspases. Caspases are constitutively
present in most cells as inactive proenzymes and are activated
by specific proteolytic cleavage. On a transcriptomic microarray,
changes in apoptosis levels will therefore likely be reflected by
changes in the levels of transcripts of apoptosis regulatory proteins
without directly affecting the transcript levels of the caspases
themselves. In the present study, the expression of antiapoptotic
members of the Bcl-2 family as well as other inhibitors of apoptosis
(IAP), were more abundant in cattle with MCF than in healthy
animals (Table 4).
However, opposing forces, stimulating cell death, were also
observed in lymphnodes of cattle with MCF. Death receptors are
cell surface receptors that send apoptosis signals to the inside of the
cell when they are bound by death ligands. Death receptors are
members of the tumor necrosis factor (TNF) receptor gene
superfamily. They all contain a homologous cytoplasmic sequence
named death domain. The best characterized death receptors and
corresponding death ligands are Fas (Fas and its ligand FasL, also
called CD95 and CD95L) and TNF (TNFR1 and its ligand TNF)
[48]. T-cell receptor (TCR) engagement, i.e. activation of T
lymphocytes leads to the expression of Fas (CD95) on the surface
of the activated T-cell, a prerequisite to undergo activation
induced cell death (AICD) [49,50]. Binding of FasL to Fas results
in trimerization of Fas, which includes the approximation of death
domains in the cytoplasmic tails of Fas. In the present study, the
FasL as well as Fas transcripts were detected at significantly higher
abundance in cattle with MCF (Table 4). FasL activity was
previously described to be induced predominantly at the
transcriptional level [51,52,53]. CD27 is another member of the
Figure 3. CD4 to CD8 ratios. The CD4 to CD8 ratios (y-axis) in blood (left panel) and inguinal lymphnodes (right panel) of healthy animals and cattle
with MCF are shown. Open circles indicate individual values, horizontal bars give median values, and standard deviations are shown by vertical brackets.
doi:10.1371/journal.pone.0006265.g003
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TNF receptor family expressed on B and T-cells. Siva, which was
found to be highly abundant in the context of MCF (Table 4), is an
intracellular ligand of CD27. It is expressed in lymphoid cells and
exhibits proapoptotic activity [54,55].
In addition, some tumor suppressor genes, i.e. retinoblastoma
protein (Rb) and LCK as well as the proapoptotic p53 were more
abundant in lymphnodes of cattle with MCF than in healthy cattle
(Table 4). Rb is known to arrest cells in the G1 phase of the cell
cycle by binding to E2F transcription factors (Reviewed by [56],
while free E2F factors are important for the induction of S phase
entry. Complexes of Rb family members and E2Fs recruit histone
deacetylase and other chromatin remodeling factors to E2F-
responsive promoters and therefore inhibit transcription from the
same [57,58,59]. However, E2F transcripts were also more
abundant, which might counter balance the arresting effect of Rb.
In T lymphocytes protein tyrosine kinases (LCK) play an
integral role in the activation of cells through various immunor-
eceptor molecules [60,61]. Apart from the activation of the cell
cycle, LCK have been shown to be involved in programmed cell
death of T lymphocytes. Gonzalez-Garcia et al showed an
induction of CD95 ligand through LCK [62]. Samraj et al
showed a positive regulation of the mitochondrial apoptosis by
LCK [63]. In our experiment LCK was highly more abundant in
the context of MCF.
Thus, both pro- and anti-apoptotic forces seemed to be induced
in cattle with MCF, which might lead to a pathogenic alteration in
the natural balance between cell survival and cell death.
Low abundance of the IL-2 transcript may explain the
disease phenotype
IL-2 is used as an essential factor for the propagation of T-cells
in culture [64]. Based on this property, IL-2 was also used for the
augmentation of T-cell responses in vivo in cancer or AIDS
patients [65,66]. Importantly, IL-2 is strictly regulated at the
mRNA level, which depends on signaling from the TCR and
CD28. The suitability of both, microarray and real-time RT-PCR,
for determining the levels of IL-2 mRNA in bovine cells and the
good correlation of the two methods has been confirmed in a
different context by others [67]. In our analysis, a significant low
abundance of the IL-2 transcript was noticed in cattle with MCF,
while CD28 and TCR transcripts were present at higher than
normal abundance. Since stimulation through CD28 in addition
to the TCR can provide a potent co-stimulatory signal to T cells
for the production of various interleukins (IL-2 and IL-6 in
particular), these observations imply that MCF is associated with a
low abundance of the IL-2 transcript.
However, the low abundance of the IL-2 transcript might be
due either to down regulation of its expression or to the loss of IL-2
producer cells. It was, therefore, interesting to note that the ratio of
CD4+ to CD8+ T-cells in lymphnodes of cattle with MCF was
decreased when compared to healthy controls. Interestingly, this
same change has been observed in the AlHV-1-based rabbit model
[41]. Yet, there, the change was associated to an increased growth
of CD8+ T-cells, which in turn cannot explain any low abundance
of the IL-2 transcript. Therefore, we like to speculate that down
regulation of IL-2 transcription may at least be partially
responsible for low abundance of the IL-2 transcript in cattle
with MCF.
Of note, the ratios between CD4+ and CD8+ T-cells were
unaffected in the periphery, when analyzed in the bloodstream of
cattle. This was in contrast to the observations made in rabbits
with AlHV-1-induced MCF [41]. This is inasmuch important that
the ratio measured in the periphery does not necessarily reflect the
picture that is found in the lymphoid organs.
Interestingly, mice lacking a functional IL-2 system develop
largely normal until the age of 4 to 6 weeks, where they start to
suffer from polyclonal expansion of T- and B-cells. This expansion
causes enlargement and non-purulent inflammation of lymph
nodes, spleen, and gut-associated lymphoid tissue due to
accumulation of activated T-cells. Similarly, a human patient
with IL-2 receptor deficiency showed also signs of T-cell
abnormalities as evidenced by lymphadenopathy, chronic inflam-
matory disorders, and lymphocytic infiltration of multiple organs
[68]. Furthermore, T-cells from mice lacking either IL-2 or the IL-
2 receptor have been reported to be resistant to activation-induced
cell death in vitro and in vivo. Alternatively, it has been proposed
that the abnormal growth rate of T-cells in association with IL-2
deficiency may be due to tolerogenic properties of IL-2, mediated
through interactions with regulatory T-cells (Treg)[69,70,71].
Since IL-2 in the lymphnode is critical for the development and
peripheral expansion of Treg (CD4+CD25+), which promote self-
tolerance by suppressing autoreactivity of T-cells as well as limiting
T-cell replication in vivo (reviewed by [31], decreased IL-2 levels
may explain the accumulation and autoreactivity of the T-cells in
MCF. In any event, the disease signs and abnormal T-cell
properties seen in mice and men without functional IL-2 system
are very reminiscent of the phenotypes associated to MCF in
cattle. Thus, it seems that lack of IL-2 may play an important, if
not central role in the development of MCF.
These observations instigate hope that it might be possible to
treat MCF in cattle by supplementing IL-2. One might argue that
it would be desirable to measure the peripheral IL-2 concentra-
tions in order to support or reject this hypothesis. However, it has
to be kept in mind that IL-2 functions mainly in the lymphnodes
and peripheral IL-2 concentrations do not necessarily correctly
reflect the micro situation in the lymphnode. Indeed, it has been
shown by others that IL-2 supplementation may have considerable
effects on the immune responses, while measurement of peripheral
IL-2 expression and applied amount of external IL-2 were not a
good indicators for its function in vivo [72,73].
Potential roles of OvHV-2 proteins and transcripts in the
development of MCF
Latency-associated nuclear antigens (LANA of HHV-8 or
SaHV-2 and EBNA-1 of EBV) have been shown to play important
roles in the development of gamma herpesvirus-associated
neoplastic diseases in humans and other primates. However, their
mode of action is associated with the expression levels or the
functions of some major protooncogenes. For example, LANA of
HHV-8 may either repress transcription of p53 [74] or direct the
p53 protein to proteasomal degradation [75]. Furthermore, it can
bind and inactivate retinoblastoma protein (Rb), thereby transac-
tivating E2F transcription [76]. Similarly, SaHV-2 LANA can
interfere with p53 or Rb functions, while EBV EBNA-1 interferes
with p53 and HAUSP (Herpesvirus associated ubiquitin-specific
protease) [77].
OvHV-2 ORF73 has been predicted to encode for a LANA
orthologue, although its function has not yet been demonstrated [27].
LANAs are supposed to bind to the origin of latent viral DNA
replication (oriP) and tether the viral DNA to the host’s chromosome
in order to allow co-replication of the viral genome with the cellular
genome uponmitosis. For this purpose, any typical LANA orthologue
needs to have DNA-binding properties, which might explain
interference with the host’s gene expression profile. Thus, binding
of the LANA protein to any locus within the host’s chromosome,
including the IL-2 locus, might affect the patterns of gene expression,
including IL-2 expression. Alternatively, the LANA protein might
undergo interactions with host proteins, similar to the interactions
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described for its orthologues in other viruses. It will be interesting to
analyze these possibilities in the future.
The second transcriptionally active region detected in cattle
with MCF spanned nucleotides 115184 to 115364 bp on the
forward strand of the viral genome. At present, one may only
speculate about the nature and significance of this transcript.
According to our results from qRT-PCR, this signal is attributable
to one transcript that may even further extend into both directions.
Although no STOP codon is evident in the +3 reading frame
within the minimal boundaries of this transcript, it does not
necessarily represent a hitherto undetected gene. According to its
sequence, it may form a hairpin structure, which can be found in
micro RNAs. Thus, it may be similar to BARTs and EBERs of
EBV or to micro RNAs, which have been described for other
viruses, including many herpesviruses [78,79,80,81]. Such RNAs
might interfere with the host’s gene expression through mecha-
nisms like siRNA or other means of silencing.
It will be interesting to address these issues in consecutive studies.
Furthermore, it remains to be established, whether or not these
observations are also true for MCF in animals other than cattle.
Conclusions
We have determined the major viral gene expression pattern in
lymphnodes of cattle with MCF. Only two sites were transcrip-
tionally active, one with the potential to express ORF73, a LANA-
orthologue, the other with some likelihood to represent a thus far
unrecognized OvHV-2 gene or, maybe, miRNAs. Overall, this
viral gene expression profile is similar to the one found in the
context of AlHV-1-associated MCF in the rabbit model [41]. The
prominent counterpart to this latent gene expression pattern on
the host’s side was a significantly lower abundance of IL-2
transcripts, an increase in lymphocyte activation, as well as
increase and decrease in apoptosis associated transcripts in
lymphnodes of cattle with MCF as compared to the same tissue
from healthy animals. Taken as a whole, these results were
consistent with one of our hypotheses, which claimed that the host
gene expression of animals with MCF was affected in a manner
that could be detected by microarray analysis and that could
explain the disease without all dysregulated cells being infected.
Since the phenotype of mice with deficient IL-2-system almost
perfectly matches the colitis observed in cattle with MCF, we
suggest that OvHV-2-linked low abundance of IL-2 transcripts
may be a key to further study the pathogenesis of MCF. Clearly, in
the present study, we did not discriminate between intracellular
regulation of IL-2 mRNA expression and relative depletion of the
lymphnode to harbor IL-2 producing cells. This important
differentiation will have to be addressed in future studies.
However, MCF may be looked at as an infectious form of IL-2-
deficiency, which occurs as a natural disease of animals.
Materials and Methods
Animals
Mediastinal lymphnodes were taken from cattle at the slaughter
house (11 healthy controls) and from 6 naturally diseased animals
originating from conventional Swiss cattle farms, which had to be
euthanized due to MCF. In addition, EDTA blood samples as well
as inguinal lymphnodes were collected from 10 cows with and 8
cows without MCF.
Construction of the OvHV-2 Agilent custom 11 k
microarray
Based on the published sequence of OvHV-2 [27] we designed
an oligonucleotide microarray for the analysis of viral gene
expression in MCF. 60mer probes were chosen to match stretches
along the entire genome [27] starting at genomic position 823 with
an interval of 30 nucleotides, such that every position was covered
by two probes. This was done for the forward as well as for the
reverse strand. Further, we selected two more probes for each
predicted open reading frame (ORF) of OvHV-2. These probes
were designed using the software Arraydesigner (Premier Biosoft,
Palo Alto, USA) and chosen such that the probe length was
between 55 and 60 nucleotides and the predicted melting
temperature was between 75uC and 80uC. The chip description
was deposited at GEO database (GPL7746). Only probes with a
quality score of ‘good’ were used. Altogether, we designed 8.876
probes targeting the viral genome. Additionally, we included 1500
oligonucleotides corresponding to known cattle genes for primary
normalization of the hybridization intensities. Using our probe
sequences, we ordered 11 k custom microarrays from Agilent.
Microarrays were produced by Agilent by in situ synthesis
technology.
Affymetrix microarray for bovine transcription profile
We used the GeneCHIPH Bovine Genome array (Affymetrix.,
P/N 900561) for the analysis of the host gene expression profile.
Total RNA preparation
Total RNA was isolated from lymph nodes of 9 cattle, two of
which were sacrificed due to MCF, the others were MCF negative.
Virus status of all animals was confirmed by real-time PCR.
Lymph node tissue was frozen in liquid nitrogen and homogenized
using a mortar and pistil. Total RNA was isolated using the
RNeasy Kit by Qiagen (order number 74106, RNeasy, Qiagen,
Hombrechtikon, Switzerland). Immediately upon homogenization
the samples were taken up in RLT buffer with 1% b-
mercaptoethanol (Sigma, Buchs, Switzerland). DNA was digested
using RNase-free DNase (Qiagen, order number 79254) at room
temperature for 15 minutes. RNA concentration was measured
using a Nanodrop 1000 (NanoDrop Technologies, Delaware,
USA). The quality of each sample was checked by a Bioanalyzer
2100 (Agilent, Waldbronn, Germany). Only those samples with
260 nm/280 nm ratio between 1.89–2.13 and a 28 S/18 S ration
within 1.5–2 were further processed.
For the purpose of RT-PCR and qRT-PCR, the extracted
RNAs were additionally subjected to removal of contaminating
DNA using the Ambion Turbo DNA-free Kit (Applied Biosystems,
Rotkreuz, Switzerland).
Fluorescent cRNA preparation for the Agilent microarray
(viral gene expression profile)
1.6–5 mg of total RNA were reverse transcribed to cDNA and
amplified and labeled to cRNA with the Agilent Low RNA Input
Linear Amplification Kit PLUS (order number 5184–3525,
Agilent). Briefly, 1.2 ml T7 Promoter Primer and 1 to 5 mg of
total RNA in a total volume of 11.5 ml were denatured at 65uC for
10 minutes. Then the reaction was placed on ice for five minutes.
After that 8.5 ml cDNA master mix consisting of 4 ml 56 first
strand buffer, 2 ml 0.1 M DTT, 1 ml 10 mM dNTP mix, 1 ml
MMLV reverse transcriptase and 0.5 ul RNaseOUT were added
to each sample and incubated at 40uC for 2 hours. Subsequently
the enzyme was heat inactivated at 65uC for 15 minutes. Then the
samples were placed on ice for five minutes. For the synthesis of
fluorescent cRNA 2.4 ml Cyanine 3 or Cyanine 5-CTP (10 mM)
and 57.6 ml transcription master mix consisting of 15.3 ml nuclease
free water, 20 ml 46 transcription buffer, 6 ml 0.1 M DTT, 8 ml
NTP Mix, 6.4 ml 50% PEG, 0.5 ml RNaseOUT, 0.6 ml inorganic
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pyrophosphatase and 0.8 ml of T7 RNA Polymerase were added
and the reaction was incubated at 40uC in the dark for 2 hours.
Labeled cRNA samples were isolated again with the RNeasy Kit
(Qiagen).
Hybridization of Agilent microarrays
From each positive animal, a Cy3- and a Cy5-labeled RNA
sample, respectively, was co-hybridized with a reference sample
with the opposite labeling and used as dye-swap pairs. As reference,
the pool of the seven OvHV-2 negative samples was used. The
specific activity of all samples as concentration of dye (pmol/ml)
divided by concentration of RNA (mg/ml) was calculated. For
fragmentation and hybridization we used the Agilent Gene
Expression kit for oligo microarrays (Agilent, order number 5188–
5242, protocol G4140-90050). Before hybridization the chips were
blocked using the 106blocking agent provided with the kit. 350 ng
of Cy3 labeled RNA and 350 ng of Cy5 labeled RNA were mixed
with 20 ml 106blocking solution (provided with the kit), 4 ml 256
fragmentation buffer and toped up with nuclease-free water to
100 ml. Fragmentation was performed at 60uC in a hybridization
oven (Agilent, G2545A) in the dark for 30 minutes. 100 ml 26
hybridization buffer was added to each tube and the microarray and
gasket slide were assembled. The slides were hybridized at 65uC, for
17 hours at 4 rpm in a hybridization oven. After the hybridization,
slides were washed twice for 1 minute in wash solution 1 (66SSPE
(Sigma, order number S2015), 0,5% N-lauroylsarcosine (Sigma,
order number L7414) in de-ionised, nuclease-free water). Then the
slides were transferred to wash solution 2 (0.066 SSPE, 0.5% N-
Lauroylsarcosine) and incubated 1 minute. After this, the slides were
transferred to an acetonitrile bath (Sigma, order number A3396)
and incubated for 1 minute. At last the rack was transferred to
Agilent stabilization and drying solution (Agilent, order number
5185–5979) and incubated for 30 seconds.
Scan and Data analysis of Agilent microarrays
Microarray slides were scanned with an Agilent microarray
scanner and the scans were quantified with the Agilent Feature
Extraction software 8.5.1.1. Background subtraction and dye
normalization for each array was performed within the Agilent
Feature Extraction software with default settings. The quantified
data was subsequently loaded into GeneSpring 7.3.1 for further
analysis. Expression data from the dye-swap pairs were averaged in
order to eliminate any potential gene-specific dye effect. Probes with
signals close to background (average signal,500) as well as probes
which were flagged as saturated by the Agilent Feature Extraction
Software were excluded. From the remaining probes the average
ratio of MCF positive vs MCV negative animals was computed.
Real-time PCR
The Taqman real-time PCR for detection of OvHV-2 DNA in
animal samples was used essentially as described previously [23].
Primers and probe are listed in Table 5.
qRT-PCR
Quantitative two-step RT-PCRs were established (specificity,
sensitivity, efficiency) for ORF73, Ov9, and intergenic RNA as
described previously [82]. Briefly, RNA was extracted and purified
from contaminating DNA as described above. The QScript cDNA
Supermix (Quanta Biosciences, VWR International, Dietikon,
Switzerland) was used for cDNA synthesis (30 min at 42uC before
inactivating the RT at 85uC for 5 min) in a volume of 20 ml. For
control reactions the same amounts of RNA template were diluted
to the same volume in RNase/DNase-free water and kept on ice
during the RT cycle. In the second step, 1 ml of cDNA (or RNA)
was mixed with 10 ml Perfecta SYBR Fastmix (Quanta) and
appropriate amounts of primers (100 nM final concentration;
Table 5) before being brought to a volume of 20 ml. The following
cycles were run to yield a detection limit of between 10 and 100
copies per sample: 10 min at 95u, 40 cycles of 5 sec at 95u and
20 sec at 60u (only 58.3u for ORF73). The melt curve was run
immediately after amplification, starting at 50uC and increasing
the temperature for 80 cycles by 0.5uC every 10 seconds.
Sensitivity and efficiency were established by using decreasing
concentrations of cloned DNA templates, whereas controls for
specificity included templates from unrelated viruses [82,83].
Conventional RT-PCR
Conventional RT-PCR for ORF25 was performed as described
by others [40]. The templates and controls used here were the
same as for qRT-PCR described above.
cRNA preparation for the Affymetrix microarray
Total RNA samples (2 mg) were reverse-transcribed into double-
stranded cDNA, in vitro transcribed in presence of biotin-labeled
nucleotides using a IVT Labeling Kit (Affymetrix Inc., P/N
900449, Santa Clara, CA), purified and quantified using BioRobot
Gene Exp–cRNA Target Prep (Qiagen AG, Switzerland). The
labeled cRNA quality was determined using a Bioanalyzer 2100.
Hybridization of the Affymetrix microarray
Biotin-labeled cRNA samples (10 mg) were fragmented ran-
domly to 35–200 bp at 94uC in Fragmentation Buffer (Affymetrix
inc., P/N 900371) and were mixed in 300 ml of Hybridization Mix
(Affymetrix Inc., P/N 900720) containing Hybridization Controls
and Control Oligonucleotide B2 (Affymetrix Inc., P/N 900454),
before hybridization to GeneCHIPH Bovine Genome arrays
(Affymetrix Inc., P/N 900561) for 16 hours at 45uC was
performed. Arrays were then washed using an Affymetrix Fluidics
Station 450 (FS450_002 protocol. An Affymetrix GeneChip
Scanner 3000 (Affymetrix Inc.) was used to measure the
fluorescent intensity emitted by the labeled target.
Statistical analysis of the Affymetrix microarray
Raw data processing was performed using the Affymetrix
GCOS 1.4 software (Affymetrix Inc.). After hybridization and
scanning, probe cell intensities were calculated and summarized
Table 5. Oligonucleotides used.
Oligonucleotide Sequence (59 to 39)
OvHV-2 forward TGG TAG GAG CAG GCT ACC GT
OvHV-2 reverse ATC ATG CTG ACC CCT TGC AG
OvHV-2 probe [6FAM]-TCC ACG CCG TCC GCA CTG TAA GA
LANA2-F GTG GAG CGT TAG GAT TGA GC
LANA2-R CAG GGC AAA ACG TAA AAA GC
Ov9-F CGG GAC CAT TAC AAG AAG
Ov9-R GCA TAA CAG AAG CAT AGC
Intergenic-F GTG TGG TGA CAC ATT CCC AG
Intergenic-R ATG TAA GAC CCC TTA GCC CC
ORF25-F ACT GCG GAC GTG GCC TAC TT
ORF25-R GTC CAG GAG GGC TCG GTG TG
doi:10.1371/journal.pone.0006265.t005
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for the respective probe sets by means of the MAS5 algorithm
[84]. To compare the expression values of the genes from chip to
chip, global scaling was performed, which resulted in the
normalization of the trimmed mean of each chip to a target
intensity (TGT value) of 500 as detailed in the statistical algorithms
description document of Affymetrix (Affymetrix, 2002, see also
[85]). Quality control measures were considered before perform-
ing the statistical analysis. These included adequate scaling factors
(between 1 and 3 for all samples) and appropriate numbers of
present calls calculated by application of signed-rank call
algorithm [86]. The efficiency of the labeling reaction and the
hybridization performance was controlled with the following
parameters: present calls and optimal 39/59 hybridization ratios
(around 1) for the housekeeping genes (GAPDH and ACO7), for
the poly A spike in controls and the prokaryotic control (BIOB,
BIOC, CREX, BIODN).
Differential transcript abundance was identified as follows: Probes
that were absent in the uninfected and the infected animals were
excluded. We considered a probe absent if it had more than one
absent call among the infected animals and more than one absent call
among the uninfected animals. Student’s t-test was applied to test the
present probes for significant infection-induced higher or lower
abundance. The magnitude of the change was computed from the
averaged values of the infected and uninfected animals.
Isolation of lymphocytes
For the isolation of lymphatic cells from lymphnodes, fat and
connective tissue were removed and the remaining tissue was cut
into small pieces and filtered through a sieve with a mesh size of
1 mm before being suspended in phosphate buffered saline solution
(PBS). After washing tree times with 50 ml PBS, low speed
centrifugation, and re-filtering for removal of aggregates, the cells
were resuspended in 10 ml PBS and filtered trough a cell strainer
with a mesh size of 100 mm (BD Falcon, Bedford, MA, USA).
Fluorescence-activated flow cytometry
CD4 and CD8 subsets were determined in combination with
CD2 staining. Anti bovine CD4 (CACT138A), anti bovine CD8
(CACT80C) and anti bovine CD2 (16-1E10) were from VMRD,
Inc, Pullmann, WA, USA). For staining, 100 ml EDTA blood or
100 ml isolated lymphnode cells (106) were added to 5 ml of pre-
diluted antibody (1/100). After incubation for 30 min at 4uC, 2 ml
of erythrocyte lysing solution (8.29 g/l NH4Cl, 1 g/l KHCO3,
37 mg/l Na2 EDTA) were added. After 3 minutes at ambient
temperature, cells were pelleted by centrifugation (3506g). The
supernate was discarded and the cells resuspended in 200 ml of
PBS supplemented with 1% fetal calf serum (FCS) and the
secondary antibodies (APC labeled anti mouse IgG1 from BD
Pharmingen, BD Biosciences, San Jose, CA, USA and goat anti
mouse IgG2a-FITC from Southern Biotech, Birmingham, AL,
USA) diluted 1/1000. After 30 min at 4uC, cells were washed with
2 ml PBS and resuspended in 250 ml PBS with 1% FCS. Finally,
cells were analyzed in a FACScalibur (BD Biosciences, San Jose,
CA, USA). A gate was set to the region corresponding to the
lymphocytes, based on the forward and side scatter diagram. A
minimum of 1000 gated events were acquired and analyzed. FL1
and FL4 double positive cells were counted.
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5 Conclusions and perspectives 
Substantial new information about OvHV-2 and MCF could be made during this PhD thesis, 
which broadened our understanding of the disease and also raised many new questions. The 
salient features of the present work are as follows: 
 
i. OvHV-2 seems to target the same cell populations in sheep (which do not succumb to 
MCF) and cattle (which succumb). Thus, a differing cellular host range in MCF-
susceptible or resistant species seems not to be a crucial factor in the disease 
pathogenesis. In sheep, the virus targeted first the CD4+ T-lymphocytes and peaked 
only later the CD8+ cells. Although similar experiments have not been made in cattle, 
it seems that the CD4+ cells are lost during the first stage of MCF, whereas the CD8+ 
cells remain and harbor the major load of OvHV-2 DNA. Therefore, the virus may 
target functionally similar cells in the different animal species but behave differently 
in them and in a species-specific way.  
ii. The predominant state of OvHV-2 throughout MCF seems to be latent, with a most 
restricted viral gene expression profile, at least in lymphnodes of cattle with MCF. 
There, only two transcriptionally active loci were detected by microarray analysis, i.e. 
the ORF73 locus and an intergenic sequence, where no viral gene had been predicted. 
However, from our experiments in rabbits, we learned that certain tissues, i.e. the 
appendix of rabbits with MCF, contain structural antigens. This was demonstrated by 
immunohistology through detecting capsid protein as well as tegument protein of 
OvHV-2 in epithelial cells and M-cells of the appendix from rabbits with MCF. Thus, 
MCF seems also to be associated with limited virus replication, specifically in selected 
tissues.  
iii. The loss of IL-2 mRNA and TGFβ mRNA were the most striking features among the 
thousands of changes that were observed by microarray in the host gene expression 
profiles of animals with MCF compared to healthy controls. Together with the silence 
of the viral IL-10 gene (Ov2.5) in animals with MCF, our data suggest that a severe 
lack, physical or functional, of regulatory T cells may be crucial for MCF 
pathogenesis. This possibility opens a new and exciting field of research and helps to 
draw a new picture of MCF and its pathogenesis.  
 
Based on these insights, new aspects can be added to the current picture of OvHV-2 biology: 
 
OvHV-2 in sheep. As previously shown, OvHV-2 circulates among sheep without causing 
disease [18,58,59,60,61,63]. Most often, the virus enters the organism through the respiratory 
route, where it replicates before targeting the lymphocytes. CD4+ lymphocytes are targeted 
first because a peak of viral DNA is found initially in this cell population. Only later, CD8+ 
lymphocytes accumulate OvHV-2 DNA [31]. At times, OvHV-2 is redirected to respiratory 
tissues, where it replicates and from where it is excreted, probably in the form of aerosols, in 
order to be transmitted to a new generation of hosts [33,34,36]. The observation that virus 
harvested from respiratory tissues is non-infectious upon intravenous application but very 
much infectious by intra nasal nebulization, suggests that OvHV-2, similar to other 
gammaherpesviruses, is able to form viruses with different tropisms [4,37]. This issue 
certainly needs further investigation. The state of OvHV-2 in sheep lymphocytes is, most 
likely, predominantly latent. It had been in our original planning to address this issue using 
sorted sheep PBMC. Unfortunately, the quality of extracted RNA did not match the 
requirements for such an analysis. However, preliminary data by real-time RT-PCR indicate 
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that at least some of the Ov genes are active in sheep lymphocytes (Meier-Trummer & 
Ackermann, ongoing work). From the present knowledge, we hypothesize that this may be of 
crucial importance for maintaining health in the infected sheep. We are convinced that the Ov 
genes do not merely represent viral luxury but that they have a very important biological 
function, which just needs to be identified.  
OvHV-2 and MCF. Infectious OvHV-2 can be harvested throughout a very narrow time 
window from nasal epithelia of newly infected sheep [36]. Such infectivity can be used to 
transmit OvHV-2 by intranasal nebulization to all sorts of susceptible animal species, i.e. 
sheep, rabbit, cattle, bison. Rabbits, cattle, and bison develop MCF upon such inoculation, 
whereas sheep remain healthy, unless inoculated with an overwhelmingly high dose of the 
virus [32]. Very little is known about what happens between the time of OvHV-2-inoculation 
and the time of development of MCF. According to a recent model in AlHV-2-associated 
MCF, the virus replicates initially in unidentified tissues before spreading to CD8+ T-cells or 
their progenitors. There, it establishes a predominantly latent infection, which is suggested to 
deregulate the infected cells, leading to their proliferation and cytotoxic behavior [92]. 
Moreover, our own data suggest that OvHV-2 may cause MCF in a very similar manner. 
Indeed, a potential driving force for this has meanwhile been identified: the RNA transcribed 
from the non-coding region of OvHV-2, which was first detected throughout the present 
work, is expressed as a multiple spliced molecule, whose introns have strong characteristics 
of a miRNA (Uster & Ackermann, ongoing work). It will be of utmost interest to test the 
hypothesis that such a miRNA has a pivotal role in the pathogenesis of MCF. It is possible 
that it could influence the biology of T-lymphocytes. Two very attractive possibilities may be: 
(1) persistent activation of infected CD8+ lymphocytes and (2) resistance of activated CTLs 
against the action of Treg. 
Co-evolution and MCF. It is not known for how long OvHV-2 has circulated among and co-
evolved with sheep. However, sheep that may fall to lethal OvHV-2-associated diseases have 
probably died out a long time ago. Similarly, OvHV-2 that is virulent for sheep died out as 
well. Nomads have domesticated sheep some 10’000 years ago. In contrast, settlers 
domesticated cattle but only several thousand years later. Moreover, cattle and sheep were 
kept preferentially separate until very recently. Consequently, cattle and other animal species 
that succumb to MCF have had much less time than sheep for participating in the co-
evolutionary process with OvHV-2. In this context, it is interesting to note that in his second 
voyage to the Americas, Columbus carried the Churra breed of sheep on his ships. Thus, it 
was not before this time that the American bison might have first encountered OvHV-2. 
Hence, bison had even less time for co-evolution with sheep than cattle. Most interestingly, 
bisons are also much more susceptible to MCF than cattle [54]. Uptake and maintenance of 
the Ov genes into the OvHV-2 genome would not make sense if they were not expressed at 
times and if they did not serve an important biological function. On one hand, it seems that 
OvHV-2 has taken up and, probably, modified the Ov genes in a manner that prevents disease 
in sheep, while still allowing for constant circulation of OvHV-2 among sheep. On the other 
hand, the Ov genes are apparently silent throughout MCF. Therefore, it is attractive to 
speculate that the Ov genes serve to maintain the health of sheep throughout infection. Thus, 
they seem to represent attenuation factors rather than virulence factors. However, such a 
model alone would not explain the occurrence of MCF. Forces that drive the disease must still 
be present. In order to be tolerated in the sheep’s organisms, OvHV-2 has to impede or 
modulate the host’s adaptive immune system. This driving force seems to be counterbalanced 
by activities provided from the Ov genes and absence of counterbalancing may explain 
emergence of MCF. At present viral miRNAs as postulated throughout this study represent 
hot candidates for providing the forces driving MCF. 
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